{"text": "for prostate was \" atypically \" low .Brenner and Hall [ 14 ] suggested in 1999 that prostate tumors might not respond to changes in fractionation in the same way as other cancers .", "label": "", "metadata": {}, "score": "36.55858"}
{"text": "Several studies of the radiobiology of prostate cancer suggest that it may be more susceptible to large fraction sizes compared with conventional fractionation of external beam radiation .", "label": "", "metadata": {}, "score": "38.89174"}
{"text": "ratio of prostate cancer was comparable to that for late - responding normal tissue or even lower because of the slow natural turnover rates in a high proportion of these tumors [ 5 ] .", "label": "", "metadata": {}, "score": "39.034397"}
{"text": "This technique can be accomplished by delivering the treatments with greater precision and accuracy .This level of precision is already inherent in proton therapy treatment delivery and thus hypo - fractionation is a prime candidate for use in cancers such as prostate cancer .", "label": "", "metadata": {}, "score": "40.1559"}
{"text": "The peculiarity that the .ratio of prostate cancer is low implies that , theoretically , a hypofractionated radiation treatment schedule would increase the therapeutic gain of radiotherapy .", "label": "", "metadata": {}, "score": "40.843575"}
{"text": "References .Brenner DJ and Hall EJ .Fractionation and Protraction for Radiotherapy of Prostate Carcinoma .Int J Radiat Oncol Biol Phys 43 : 1095 - 1101 , 1999 .", "label": "", "metadata": {}, "score": "44.863274"}
{"text": "Long - term bRFS rates are encouraging .Urinary and rectal toxicities are limited .High - dose hypofractionation is an alternative to dose escalation for localized prostate cancer .", "label": "", "metadata": {}, "score": "45.413994"}
{"text": "Hypofractionated radiotherapy for prostate cancer has become of increasing interest with the recognition of a potential improvement in therapeutic outcome with treatments delivered in large - sized daily fractions .", "label": "", "metadata": {}, "score": "46.256893"}
{"text": "A megavoltage CT scan was obtained prior to each fraction for verification of treatment position .A more than 5 mm displacement of the isocenter mandated repositioning of the patient .", "label": "", "metadata": {}, "score": "46.39911"}
{"text": "ratio is consistent with a greater capacity for repair between fractions , with an accompanying greater relative sparing with small fraction sizes , than for tumors with their typically higher . ratios .", "label": "", "metadata": {}, "score": "46.483456"}
{"text": "Brenner DJ , Hall EJ : Fractionation and protraction for radiotherapy of prostate carcinoma .Int J Radiat Oncol Biol Phys 1999 , 43 : 1095 - 101 .", "label": "", "metadata": {}, "score": "46.647923"}
{"text": "Emerging radiobiological data indicates that prostate cancer has a low a / \u03b2 -ratio of 1.2 - 3.0 Gy [ 22 - 24 ] , suggesting that biological dose escalation can be achieved by hypofractionated treatment schemes .", "label": "", "metadata": {}, "score": "47.111107"}
{"text": "Abstract].Strahlenther Onkol 2007 , 183 : 125 .Sondernr 1 .Brenner DJ , Martinez AA , Edmundson GK , Mitchell C , Thames HD , Armour EP : Direct evidence that prostate tumors show high sensitivity to fractionation ( low alpha / beta ratio ) , similar to late - responding normal tissue .", "label": "", "metadata": {}, "score": "47.359924"}
{"text": "It is though important to mention that although these two clinical trials show low rates of morbidity , taking into consideration the long natural history of prostate cancer and the heterogeneity of patients within risk groupings , it is difficult to draw inference on treatment efficacy .", "label": "", "metadata": {}, "score": "47.378307"}
{"text": "PubMed View Article .Martinez AA , Demanes J , Vargas C , Schour L , Ghilezan M , Gustafson GS : High - dose - rate prostate brachytherapy : an excellent accelerated - hypofractionated treatment for favorable prostate cancer .", "label": "", "metadata": {}, "score": "47.790794"}
{"text": "However , treatment assignment was in all cases at the discretion of the treating physician .Patients were considered ineligible for monotherapy in cases of nodal or other distant metastases , previous pelvic EBRT for another malignant diagnosis or previous open surgery of the prostate .", "label": "", "metadata": {}, "score": "47.835545"}
{"text": "S. G. Williams , J. M. G. Taylor , N. Liu et al . , \" Use of individual fraction size data from 3756 patients to directly determine the \u03b1 / \u03b2 ratio of prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "48.002815"}
{"text": "View at Google Scholar . H. Lukka , C. Hayter , and P. A. Warde , \" Randomized trial comparing two fractionation schedules for patients with localized prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "48.019398"}
{"text": "Finally , the presence of seminal vesicle invasion or large prostate gland volumes extending beyond the bony pelvic inlet , also disqualify patients for monotherapy [ 28 ] .", "label": "", "metadata": {}, "score": "48.235416"}
{"text": "ACCELERATED FRACTIONATION Same dose delivered rapidly to treat the rapidly proliferating tumors .CONTINUOUS HYPER FRACTIONATION RADIOTHERAPY ( CHART ) Extreme accelerated schedules Consists of giving three daily radiation treatments of 1.5Gy each to a total dose of 54Gy without giving any weekend breaks .", "label": "", "metadata": {}, "score": "48.253716"}
{"text": "PubMed View Article . D'AmicoAV , Whittington R , Malkowicz SB : Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era .", "label": "", "metadata": {}, "score": "48.81252"}
{"text": "Clinical Implications .Hypofractionated radiation has drawn significant attention for prostate cancer as it has the potential to take advantage of the low alpha / beta ratio for prostate cancer , it offers the convenience of decreased treatment times for patients , and it is more cost effective for the healthcare system .", "label": "", "metadata": {}, "score": "48.823746"}
{"text": "[ 7 ] , Bentzen and Ritter [ 6 ] showed remarkable agreement with the conclusion of Brenner and Hall 's 1999 conclusions .These estimates are consistent with the very slow proliferation characteristics of prostate tumors in comparison with other malignancies .", "label": "", "metadata": {}, "score": "49.28492"}
{"text": "References .Mark R , Anderson P , Akins R : Interstitial high - dose - rate brachytherapy as monotherapy for early stage prostate cancer : Median 8-year results in 301 patients .", "label": "", "metadata": {}, "score": "49.42061"}
{"text": "PubMed View Article .Prada PJ , Jimenez I , Gonz\u00e1lez - Su\u00e1rez H , Fern\u00e1ndez J , Cuervo - Arango C , Mendez L : High - dose - rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer : treatment description and preliminary results .", "label": "", "metadata": {}, "score": "49.472813"}
{"text": "The threshold fraction size above which this risk is clinically significant is difficult to determine .One reason is the considerable variation in the fractionation regimens used [ 9 ] and the major difference in the prognostic characteristics of the patients in whom the regimen was studied .", "label": "", "metadata": {}, "score": "49.47571"}
{"text": "The principle of \u03b1 /\u03b2 has always been instrumental in guiding radiation therapy fractionation and doses .With the prostate having an \u03b1 /\u03b2 of 1.5 - 3 , while the rectum and bladder are 4 - 6 , and 7 respectively , hypofractionation in localized prostate cancer could be an alternative approach to standard treatment .", "label": "", "metadata": {}, "score": "49.57744"}
{"text": "Lotan Y , Stanfield J , Cho C , et al .Efficacy of High - Dose per Fraction Radiation for Implanted Human Prostate Cancer in a Nude Mouse Model .", "label": "", "metadata": {}, "score": "49.675915"}
{"text": "PubMed View Article .Hoskin P , Rojas A , Lowe G : High - dose - rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence .", "label": "", "metadata": {}, "score": "49.687984"}
{"text": "Since the early reports of hypofractionation , there has been a steady increase in reports of hypofractionated radiotherapy for prostate cancer .Some have decreased the number of fractions modestly , and others have reduced it to only five sessions [ 41 - 50 ] .", "label": "", "metadata": {}, "score": "49.755215"}
{"text": "Background .Dose escalation has been shown in a number of prospective randomized trials to improved biochemical recurrence free survival for prostate cancer .It has also been suggested that the ? ratio for prostate cancer is low at 1.5 Gy .", "label": "", "metadata": {}, "score": "50.272984"}
{"text": "As though their suggestion was that the .ratio for prostate cancer might be low ( 1.5 ) comparable to that of late sequelae .Recent analysis of clinical data by Fowler et al .", "label": "", "metadata": {}, "score": "50.44758"}
{"text": "In that publication , they reported the hypofractionated arm was associated with slight increased acute GI toxicity within the first month , which was predicted by the rectal V65 Gy ( volume of rectum receiving 65 Gy ) .", "label": "", "metadata": {}, "score": "50.59551"}
{"text": "All treatments were completed within 10 days with a minimum of 12 hours between fractions .The planning target volume ( PTV ) was prostate only with 3 - 5 mm expansion .", "label": "", "metadata": {}, "score": "50.67077"}
{"text": "This rate of erectile preservation is consistent with data reported in recent publications on HDR monotherapy [ 8 , 26 , 27 ] .The consistently low level of severe acute and late toxicities in HDR BRT likely reflects the precision of 3D dosimetry , which can reduce uncertainties in dose distribution and thereby allow for better sparing of critical organs [ 28 ] .", "label": "", "metadata": {}, "score": "50.69303"}
{"text": "Extent of surgical resection was recorded based on operative report and postoperative imaging .Radiation therapy .All patients were treated with HT using a 6 MV linear accelerator .", "label": "", "metadata": {}, "score": "50.817436"}
{"text": "This article has been retracted as it is found to contain a substantial amount of material from the paper \" Hypofractionation for Prostate Cancer :A Critical Review , \" Edward F. Miles , W. Robert Lee , Seminars in Radiation Oncology - January 2008 ( Vol .", "label": "", "metadata": {}, "score": "51.061195"}
{"text": "Late toxicity included 4.2 % RTG grade 2 rectal , 7.8 % grade 2 urinary , and 1.4 % grade 3 urinary .Mean Expanded Prostate Cancer Index Composite ( EPIC ) score for urinary and bowel QOL declined at 1 month post - treatment and returned to baseline by 2 years .", "label": "", "metadata": {}, "score": "51.138065"}
{"text": "More specifically , if .ratio for prostate cancer is lower than the nearby normal tissues , then the therapeutic advantage can be gained by using fewer and larger fractions .", "label": "", "metadata": {}, "score": "51.237114"}
{"text": "PubMed View Article .Dearnaley DP , Sydes MR , Graham JD : Escalated - dose versus standard - dose conformal radiotherapy in prostate cancer : first results from the MRC RT01 randomised controlled trial .", "label": "", "metadata": {}, "score": "51.24151"}
{"text": "Clinical / Scientific Implications .This study explores the idea that if the alpha - beta ratio for the prostate is lower than that of the surrounding normal tissues ( rectum and bladder ) , then it would be logical to use hypofractionation for the treatment of localized prostate cancer .", "label": "", "metadata": {}, "score": "51.26007"}
{"text": "Treatment was delivered using a 5-field IMRT plan , prescribed to 70Gy at 2.5Gy per fraction over 5.5 weeks .Transabdominal ultrasound was used daily to localize the prostate .", "label": "", "metadata": {}, "score": "51.4213"}
{"text": "PubMed View Article .Corner C , Rojas AM , Bryant L , Ostler P , Hoskin P : A phase II study of high - dose - rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer .", "label": "", "metadata": {}, "score": "51.48253"}
{"text": "View at Google Scholar . Y. Lotan , J. Stanfield , L. C. Cho et al . , \" Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model , \" Journal of Urology , vol .", "label": "", "metadata": {}, "score": "51.491432"}
{"text": "In this trial , the 5-year rate of failure ( biochemical or clinical ) was higher in the hypofractionated arm compared to the standard fractionation arm ( 60 % versus 53 % , .", "label": "", "metadata": {}, "score": "51.513287"}
{"text": "[17 ] reported a British dose escalation study for prostate cancer using hypofractionated IMRT regimen using a higher dose per fraction .Patients received 57 - 60 Gy to the prostate in 19 - 20 fractions using five - field IMRT .", "label": "", "metadata": {}, "score": "51.528347"}
{"text": "All recurrences occurred within 2 cm of the original gross tumour volume ( GTV ) .No cases of pseudoprogression were identified in our cohort of patients .", "label": "", "metadata": {}, "score": "51.661247"}
{"text": "Another study performed by Brenner et al .[ 4 ] in more than 120,000 patients with prostate cancer showed an increased cancer risk after radiotherapy of 6 % if compared to the group that underwent only surgery .", "label": "", "metadata": {}, "score": "51.712627"}
{"text": "Post Hoc Analysis of Retrospective Clinical Trials .The article concerned with the low .ratio hypothesis of prostate cancer was first published in 1999 by Brenner and Hall [ 14 ] .", "label": "", "metadata": {}, "score": "51.748066"}
{"text": "The study 's inability to show improved outcome , over standard fractionation , could be due to our reluctance to proceed to higher dose levels or merely a reflection of the small sample size tested .", "label": "", "metadata": {}, "score": "51.812843"}
{"text": "However , the 3-year freedom from biochemical failure rates were 87 % and 79 % in the hypofractionation and conventional fractionation groups , respectively ( .", "label": "", "metadata": {}, "score": "51.883057"}
{"text": "PubMed View Article .Zelefsky MJ , Leibel SA , Gaudin PB : Dose escalation with three - dimensional conformal radiation therapy affects the outcome in prostate cancer .", "label": "", "metadata": {}, "score": "52.035946"}
{"text": "The therapy was generally well tolerated , and few patients had late complications .More specifically , two patients developed rectal strictures , and a few patients had recurrent rectal bleeding episodes .", "label": "", "metadata": {}, "score": "52.0751"}
{"text": "PubMed View Article .Ghadjar P , Keller T , Rentsch CA : Toxicity and early treatment outcomes in low- and intermediate - risk prostate cancer managed by high - dose - rate brachytherapy as a monotherapy .", "label": "", "metadata": {}, "score": "52.78753"}
{"text": "PubMed View Article .Rogers CL , Alder SC , Rogers RL : High dose brachytherapy as monotherapy for intermediate risk prostate cancer .J Urol 2012 , 187 : 109 - 16 .", "label": "", "metadata": {}, "score": "52.999756"}
{"text": "ratio for prostate cancer is widely believed to be in the range 1 - 4 Gy [ 7 - 12 ] .In this context , it has been hypothesized that the therapeutic ratio would be enhanced by increasing the dose per fraction to the prostate cancer above the standard range [ 8 - 12 ] .", "label": "", "metadata": {}, "score": "53.09208"}
{"text": "PubMed View Article .Barkati M , Williams SG , Foroudi F : High - dose - rate brachytherapy as a monotherapy for favorable - risk prostate cancer : a phase II trial .", "label": "", "metadata": {}, "score": "53.1318"}
{"text": "The second category includes clinical trials of hypofractionated regimens that did not depend on the .ratio hypothesis .The third category includes prospective phase I to II studies using fractionation regimens that assumed that the .", "label": "", "metadata": {}, "score": "53.140892"}
{"text": "In this phase I study , a dose escalation protocol using two dose levels , was also used to determine a safe radiation fractionation regimen .", "label": "", "metadata": {}, "score": "53.198757"}
{"text": "While conventional fractionation radiation regimens are usually employing fractions of 1.8 - 2.0 Gy daily , hypofractionation , as the name suggests , refers to the delivery of radiotherapy dose in smaller number of treatments that would be used to deliver a traditional dosing scheme .", "label": "", "metadata": {}, "score": "53.20038"}
{"text": "The development of reliable secondary cancer risk models seems to be a key issue in fractionated radiotherapy and comparisons of integral dose received with 3D - CRT and other special techniques are strongly encouraged .", "label": "", "metadata": {}, "score": "53.21788"}
{"text": "Laser guided radiation .Hypofractionated Intensity Modulated Radiotherapy ( 70 Gy at 2.5Gy Per Fraction ) for Localized Prostate Cancer : Long - Term Outcome Results .", "label": "", "metadata": {}, "score": "53.256847"}
{"text": "PubMed View Article .Roach M , Hanks G , Thames H : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG - ASTRO Phoenix Consensus Conference .", "label": "", "metadata": {}, "score": "53.27307"}
{"text": "Battermann JJ , Boon TA , Moerland MA : Results of permanent prostate brachytherapy , 13 years of experience at a single institution .Radiother Oncol 2004 , 71 : 23 - 28 .", "label": "", "metadata": {}, "score": "53.385586"}
{"text": "Three - dimensional conformal radiotherapy and IMRT were allowed .Mature results of the study are not yet available .The dose per fraction was 2.625 Gy , slightly higher than the fractional dose used by Kupelian et al .", "label": "", "metadata": {}, "score": "53.433548"}
{"text": "[47 ] first reported their institutional experience using hypofractionation to treat safely an initial 100 consecutive patients with localized prostate cancer .Subsequently , an expanded experience involving 770 patients was reported [ 48 ] .", "label": "", "metadata": {}, "score": "53.466187"}
{"text": "In recent years there has been increasing interest in hypofractionated radiotherapy for prostate cancer .A significant number of reports have suggested that .ratio for prostate cancer is low .", "label": "", "metadata": {}, "score": "53.491745"}
{"text": "Zelefsky MJ , Kuban DA , Levy LB : Multi - institutional analysis of long - term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation .", "label": "", "metadata": {}, "score": "53.567024"}
{"text": "In most cases the prostate cancer is organ - confined at the time of initial diagnosis [ 2 ] .Regarding the specific option of external beam radiotherapy , the current widely accepted standard regimen for organ - confined prostate cancer in the USA involves approximately eight weeks of fractionated treatments with a daily dose of 1.8 - 2.0 Gy to a total dose in the range of 70 - 80 Gy .", "label": "", "metadata": {}, "score": "53.60491"}
{"text": "This issue is not trivial since ID calculation does not consider fractionation effects , which are supposed to play a key role in radiation - induced malignancies .", "label": "", "metadata": {}, "score": "53.617516"}
{"text": "References .Cancer Facts and Figures 2012 , American Cancer Society , 2012 . E. L. Paquette , L. Sun , L. R. Paquette , R. Connelly , D. G. Mcleod , and J. W. Moul , \" Improved prostate cancer - specific survival and other disease parameters : impact of prostate - specific antigen testing , \" Urology , vol .", "label": "", "metadata": {}, "score": "53.619278"}
{"text": "Materials and Methods .100 patients accrued from 1998 - 1999 with stage T1-T3 disease were evaluated .The lateral and posterior margins on the prostate \u00b1 seminal vesicles were 8 mm and 4 mm posteriorly .", "label": "", "metadata": {}, "score": "53.71911"}
{"text": "Secondly , if on the one hand these techniques lead to tight dose conformations and sharp dose gradients , on the other they are likely to increase the integral dose exposure to non - tumor tissues since larger volumes of normal tissues can be exposed to lower doses [ 6 ] .", "label": "", "metadata": {}, "score": "53.87424"}
{"text": "It is already well established from multiple studies of standard fractionation , in which a low dose of radiation is given five days a week for 8 - 9 weeks , that the best cancer control results are obtained with higher doses .", "label": "", "metadata": {}, "score": "53.882256"}
{"text": "The 3-year freedom from biochemical failure rates were 87 % and 79 % in the hypofractionation and conventional fractionation groups , respectively ( . )", "label": "", "metadata": {}, "score": "53.99259"}
{"text": "Transrectal ultrasound .TURP : .Transurethral resection of the prostate .US : .Ultrasound .3D : . three - dimensional .Declarations .", "label": "", "metadata": {}, "score": "53.998272"}
{"text": "Isodose distribution after anatomy - based dose optimisation .The 100 % isodose was set to encompass the red delineated prostate capsule .All implants were performed under spinal , or if indicated , general anaesthesia with the patient in the high lithotomy position using a perineal template .", "label": "", "metadata": {}, "score": "53.99882"}
{"text": "We encountered 3.4 % late Grade 3 genitourinary toxicity with seven patients developing strictures requiring urethrotomy .Late Grade 3 rectal morbidity was 1.4 % overall with one patient requiring endoscopic restoration of bowel continuity after rectal biopsy associated ulcer development .", "label": "", "metadata": {}, "score": "54.08179"}
{"text": "View at Google Scholar .C. I. Tang , D. A. Loblaw , P. Cheung et al . , \" Phase I / II study of a five - fraction hypofractionated accelerated radiotherapy treatment for low - risk localised prostate cancer : early results of pHART3 , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "54.086014"}
{"text": "PubMed View Article .Fowler J , Chappell R , Ritter M : Is alpha / beta for prostate tumors really low ?Int J Radiat Oncol Biol Phys 2001 , 50 : 1021 - 31 .", "label": "", "metadata": {}, "score": "54.10669"}
{"text": "G. W. Jones , C. Mettlin , G. P. Murphy et al . , \" Patterns of care for carcinoma of the prostate gland : results of a national survey of 1984 and 1990 , \" Journal of the American College of Surgeons , vol .", "label": "", "metadata": {}, "score": "54.146362"}
{"text": "6 , article 358 , 1991 .View at Google Scholar \u00b7 View at Scopus .J. E. Livsey , R. A. Cowan , J. P. Wylie et al . , \" Hypofractionated conformal radiotherapy in carcinoma of the prostate : five - year outcome analysis , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "54.158634"}
{"text": "An added complexity is that it is not clear whether the traditional linear quadratic model continuing to model closely the radiation dose - response in tumors applies for fractional doses in the range of 6 - 8 Gy or higher [ 36 - 38 ] .", "label": "", "metadata": {}, "score": "54.209915"}
{"text": "Several randomized trials , including this trial , have demonstrated the efficacy of hypofractionation with prostate cancer .In fact , within this trial , less failures were seen than anticipated .", "label": "", "metadata": {}, "score": "54.31301"}
{"text": "There were 303 assessable patients entered between 2002 and 2006 .There were 152 patients assigned to receive standard fractionation and 151 patients assigned to receive hypofractionation .", "label": "", "metadata": {}, "score": "54.35218"}
{"text": "The target volumes included prostate and seminal vesicle without incorporation of regional lymph nodes .All patients received neoadjuvant hormonal therapy for 3 months before radiotherapy to a maximum of 6 months .", "label": "", "metadata": {}, "score": "54.37687"}
{"text": "This impact could be even lower if our plans for reducing the cost for proton therapy for prostate cancer through hypo - fractionation are embraced by commercial payers as we believe they will .", "label": "", "metadata": {}, "score": "54.394367"}
{"text": "127 - 132 , 1991 .View at Google Scholar \u00b7 View at Scopus .W. Duncan , P. Warde , C. N. Catton et al . , \" Carcinoma of the prostate : results of radical radiotherapy ( 1970 - 1985 ) , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "54.424675"}
{"text": "In our cohort , Gleason score , pre - treatment PSA , and clinical stage did not attain statistical significance using Kaplan - Meier actuarial estimates of freedom from biochemical failure .", "label": "", "metadata": {}, "score": "54.44804"}
{"text": "PubMed View Article .Demanes DJ , Martinez AA , Ghilezan M : High - dose - rate monotherapy : safe and effective brachytherapy for patients with localized prostate cancer .", "label": "", "metadata": {}, "score": "54.483837"}
{"text": "The purpose of this study was to compare the toxicity and efficacy of hypofractionated ( 62 Gy/20 fractions/5 weeks , 4 fractions per week ) versus conventional fractionation radiotherapy ( 80 Gy/40 fractions/8 weeks ) .", "label": "", "metadata": {}, "score": "54.5076"}
{"text": "PubMed View Article .Zamboglou N , Tselis N , Baltas D : High - dose - rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer : treatment evolution and mature results .", "label": "", "metadata": {}, "score": "54.530453"}
{"text": "When a large tumor are midline lesion is present a parallel opposed field setup may be needed , which produced a uniform exposure for midline disease .", "label": "", "metadata": {}, "score": "54.562275"}
{"text": "Discussion .Hypo - IMRT using HT is an approach that combines high - precision RT delivery and a hypofractionated regimen .Patients with GBM have a dismal prognosis and a limited life span .", "label": "", "metadata": {}, "score": "54.621895"}
{"text": "11 - 18 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Norkus , A. Miller , J. Kurtinaitis et al . , \" A randomized trial comparing hypofractionated and conventionally fractionated three - dimensional external - beam radiotherapy for localized prostate adenocarcinoma : AAAAA report on acute toxicity , \" Strahlentherapie und Onkologie , vol .", "label": "", "metadata": {}, "score": "54.627647"}
{"text": "All patients were treated with tomotherapy or linac based IMRT with daily image guidance .Three hundred seven patients with favorable to intermediate risk prostate cancer was accrued .", "label": "", "metadata": {}, "score": "54.63726"}
{"text": "S80-S81 , 2009 .View at Google Scholar .C. Menkarios , T. Vigneault , N. Brochet et al . , \" Toxicity report of once weekly radiation therapy for low - risk prostate adenocarcinoma : preliminary results of a phase I / II trial , \" Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "54.663933"}
{"text": "The transperineal approach in high dorsal lithotomy position enables adequate implantation of volumes appreciably greater than 50 cc provided there is a sufficiently broad pelvic inlet and low pre - treatment urinary symptom scores .", "label": "", "metadata": {}, "score": "54.796677"}
{"text": "In all patients , PSA control was 100 % by the Phoenix definition .In light of the accumulating clinical evidence for hypofractionation , RTOG 0938 [ 66 ] has been initiated in the USA It is a prospective randomized phase II trial that will compare 36.25 Gy in 5 fractions of 7.25 Gy to 51.6 Gy in 12 fractions of 4.3 Gy .", "label": "", "metadata": {}, "score": "54.93899"}
{"text": "This recommendation is also suggested by the smaller difference found between the experimental and the predicted percentage depth doses ( PDDs ) inside the lung , when correction - based algorithms are used [ 32 ] .", "label": "", "metadata": {}, "score": "55.07331"}
{"text": "Other investigators have used similar 3 Gy per fractions in hypofractionated treatments .The clinical target volume includes the prostate and a base of seminal vesicles .", "label": "", "metadata": {}, "score": "55.13973"}
{"text": "Abstract].Brachytherapy 2010 , 9 : 76 .View Article .Yoshioka Y , Konishi K , Sumida I : Monotherapeutic high - dose - rate brachytherapy for prostate cancer : five - year results of an extreme hypofractionation regimen with 54 Gy in nine fractions .", "label": "", "metadata": {}, "score": "55.22835"}
{"text": "One was using external beam radiation therapy and the other was using permanent brachytherapy .The authors used the standard linear - quadratic model and disease - free estimates relied on PSA values .", "label": "", "metadata": {}, "score": "55.262882"}
{"text": "Although many patients have been successfully treated with radiotherapy regimens of this nature , the optimal radiation schedule for the curative treatment of prostate cancer remains an unsettled question .", "label": "", "metadata": {}, "score": "55.291008"}
{"text": "However , there is more to the story .Prostate cancer is known to be one of the slower growing tumor types .Because the proliferation of prostate cancer cells is low , it is believed that these cells are more sensitive to higher doses per fraction than are other cancers .", "label": "", "metadata": {}, "score": "55.384453"}
{"text": "A high rate of cerebral necrosis was noted using this regimen which resulted in earlier termination of patient enrolment .Sultamen et al .[ 3 ] prescribed 60 Gy in 20 fractions to the GTV and 40 Gy in 20 fractions to the PTV in their study .", "label": "", "metadata": {}, "score": "55.48908"}
{"text": "of the surrounding normal tissues ( bladder and rectum ) , then hypofractionated regimens should result in an improved therapeutic outcome .There is now convincing evidence that biochemical control is improved with higher cumulative radiation doses to the prostate .", "label": "", "metadata": {}, "score": "55.52651"}
{"text": "A univariate analysis using the Cox proportional regression analysis was used to examine the effect of multiple prognostic factors on PFS and OS .These factors included KPS , recursive partitioning analysis ( RPA ) class [ 8 ] , type of surgery performed ( biopsy vs. subtotal or gross total resection ) , time interval between the surgery and start of RT and number of adjuvant Temozolomide cycles .", "label": "", "metadata": {}, "score": "55.531857"}
{"text": "The 4-year PSA relapse - free survival was 94 % .Katz et al .[ 50 , 64 ] reported an experience of SBRT treatment given to 304 patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "55.673294"}
{"text": "In our study , unless otherwise clinically indicated , an MRI was first routinely performed after three months of the end of RT .Accordingly , only nine cases were classified as early progression and all of which were true disease progression .", "label": "", "metadata": {}, "score": "55.707733"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Brenner , D.J. The linear - quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction .", "label": "", "metadata": {}, "score": "55.716896"}
{"text": "11 , pp .715 - 721 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Norkus , A. Miller , A. Plieskiene , E. Janulionis , and K. P. Valuckas , \" A randomized trial comparing hypofractionated and conventionally fractionated three - dimensional conformal external - beam radiotherapy for localized prostate adenocarcinoma : a report on the first - year biochemical response , \" Medicina , vol .", "label": "", "metadata": {}, "score": "55.71956"}
{"text": "Hypofractionated radiation therapy offers the advantage of a shorter treatment period which is imperative in this group of patients with limited life expectancy .Keywords .", "label": "", "metadata": {}, "score": "55.793312"}
{"text": "PubMed View Article .Yamada Y , Rogers L , Demanes DJ : American Brachytherapy Society consensus guidelines for high - dose - rate prostate brachytherapy .", "label": "", "metadata": {}, "score": "55.79638"}
{"text": "PubMed View Article .Peddada AV , Jennings SB , Faricy PO , Walsh RA , White GA , Monroe AT : Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection .", "label": "", "metadata": {}, "score": "55.79996"}
{"text": "Besides the healthcare systems , prostate cancer is considered to have an impact on society as well , as far as biologic , economic , and personal parameters are concerned .", "label": "", "metadata": {}, "score": "56.052597"}
{"text": "There is convincing evidence , by several clinical trials , that biochemical control is significantly improved with higher administered radiation doses to the prostate gland .", "label": "", "metadata": {}, "score": "56.09574"}
{"text": "Retrospective Clinical Trials with Hypofractionated Radiotherapy for Prostate Cancer .Hypofractionated radiotherapy regimens have been used for several decades , primarily due to the low availability of treatment machines .", "label": "", "metadata": {}, "score": "56.115513"}
{"text": "Written informed consent was obtained from all patients .In our series we had one patient with T3 disease , who was staged T3a .The PTV in this case was defined by the prostate capsule plus 5.0 mm in all directions ( except for the posterior rectal margin ) .", "label": "", "metadata": {}, "score": "56.20382"}
{"text": "4 , pp .687 - 691 , 1986 .View at Google Scholar \u00b7 View at Scopus . F. Leborgne , J. Fowler , J. H. Leborgne , and J. Mezzera , \" Later outcomes and alpha / beta estimate from hypofractionated conformal three - dimensional radiotherapy versus standard fractionation for localized prostate cancer , \" International Journal of Radiation Oncology , Biology , Physics , vol .", "label": "", "metadata": {}, "score": "56.242657"}
{"text": "Patient selection and characteristics .Since 2002 , we have treated more than 900 patients with HDR monotherapy for clinically localised prostate cancer .During this period , three different protocols were implemented reflecting an evolution aiming to improve clinical workflow and patient comfort .", "label": "", "metadata": {}, "score": "56.25673"}
{"text": "View at Google Scholar . E. E. K. Yeoh , R. J. Fraser , R. E. McGowan et al . , \" Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma : early results of a Phase III randomized trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "56.27532"}
{"text": "Unfortunately , dose escalation using a conventionally fractionated treatment schedule requires a lengthened treatment course that is less convenient for patients and more costly for government and private insurance carriers .", "label": "", "metadata": {}, "score": "56.281803"}
{"text": "The findings of the present analysis confirm monotherapeutic HDR BRT to be a safe and effective modality for clinically localised prostate cancer .Three - dimensional TRUS - based intraoperative real - time treatment planning provided accurate dosimetry with precise radiation delivery ensuring an acceptable side effect profile .", "label": "", "metadata": {}, "score": "56.329414"}
{"text": "ratio of 1.5 Gy .They concluded that the calculated .ratio argued for hypofractionation regimens using high - dose rate ( HDR ) brachytherapy or external beam radiation therapy .", "label": "", "metadata": {}, "score": "56.372795"}
{"text": "The same study by Brandes et al .[15 ] also reported strong correlation between the recurrence pattern and the MGMT methylation status .The rate of infield recurrence correlated significantly with MGMT methylation status .", "label": "", "metadata": {}, "score": "56.45273"}
{"text": "Eight patients with intrathoracic lesions were treated with SBRT , 23 Gy \u00d7 1 fraction .All patients were then replanned for 3D - CRT , maintaining the same target coverage and applying a dose scheme of 2 Gy \u00d7 32 fractions .", "label": "", "metadata": {}, "score": "56.473816"}
{"text": "The authors used image - guided IMRT to treat men with localized prostate cancer using 2.5 Gy fractions to 70 Gy .The observed gastrointestinal and genitourinary morbidity in this trial was acceptable .", "label": "", "metadata": {}, "score": "56.64553"}
{"text": "The median follow - up was 32 and 35 months in the hypofractionation and conventional fractionation arms , respectively .No difference was found for late toxicity between the two treatment groups .", "label": "", "metadata": {}, "score": "56.683964"}
{"text": "It is estimated that about 30 % of all prostate cancer patients will receive radiotherapy [ 1 ] , and a significant number of these patients will eventually be cured .", "label": "", "metadata": {}, "score": "56.93133"}
{"text": "There are radiobiological rationales supporting hypofractionated radiotherapy for prostate cancer .The recent advancements in treatment planning and delivery allow sophisticated radiation treatments to take advantage of the differences in radiobiology of prostate cancer and the surrounding normal tissues .", "label": "", "metadata": {}, "score": "57.12039"}
{"text": "Panet - Raymond et al .[ 4 ] did a retrospective analysis on 35 patients who were treated with post - operative Hypo - IMRT and TMZ according to the Stupp protocol .", "label": "", "metadata": {}, "score": "57.1335"}
{"text": "They report that the hypofractionated arm had similar toxicity with improved biochemical failure rates .Further follow up is needed to ensure there are not differences in late failures between the treatment arms .", "label": "", "metadata": {}, "score": "57.405148"}
{"text": "At a median followup of 90 months , biochemical relapse - free survival ( bRFS ) was significantly better with hypofractionation when Phoenix definition was used ( 53 % versus 34 % , . )", "label": "", "metadata": {}, "score": "57.529415"}
{"text": "Patients in the hypofractionated groups received either 60 Gy in 20 fractions or 57 Gy in 19 fractions .All treatments were 5 fractions per week .", "label": "", "metadata": {}, "score": "57.599995"}
{"text": "The delivery of Hypo - IMRT with concomitant and adjuvant TMZ was found to be safe and feasible .The PFS and OS were comparable to those reported with conventional fractionation regimen .", "label": "", "metadata": {}, "score": "57.633354"}
{"text": "Before the delivery of next dos of radiation sublethal damage repair can occur in both the tumor and normal tissues .Because a substantial number of cells within the tumor have been killed by the first dose of radiation , there is less competition for the available oxygen , and some of the hypoxic tumor cells can re - oxygenate and become more radiosensitive .", "label": "", "metadata": {}, "score": "57.67373"}
{"text": "PubMed View Article .Martinez AA , Pataki I , Edmundson G , Sebastian E , Brabbins D , Gustafson G : Phase II prospective study of the use of conformal high - dose - rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer : a feasibility report .", "label": "", "metadata": {}, "score": "57.877174"}
{"text": "[ 12 - 14 ] or radical prostatectomy [ 15 ] .In the absence of randomised clinical trials of sufficient size , however , the optimal therapeutic strategy for organ - confined disease remains controversial and treatment assignment appears influenced by physician bias and patient preference .", "label": "", "metadata": {}, "score": "57.900078"}
{"text": "Only the 45 Gy group demonstrated sustained PSA and tumor volume decreases in most mice [ 65 ] .This preclinical data supported the clinical trial launched by Boike and colleagues at UTSW [ 59 ] , who conducted a phase I study that escalated the total doses from 45 Gy to 50 Gy in 5 fractions .", "label": "", "metadata": {}, "score": "57.928047"}
{"text": "ratio of 3 for late normal tissue effects .The treatments were delivered with 3 Gy per fraction , 5 days per week for 4 consecutive weeks to a minimum dose of 60 Gy to the CTV ( entire prostate and the base of seminal vesicles ) .", "label": "", "metadata": {}, "score": "57.943012"}
{"text": "Furthermore , integral dose does not consider fractionation at all , and fractionation is supposed to be directly correlated to an increased cancer risk [ 31 ] .", "label": "", "metadata": {}, "score": "57.990616"}
{"text": "PubMed View Article .Pollack A , Zagars GK , Starkschall G : Prostate cancer radiation dose response : results of the M. D. Anderson phase III randomized trial .", "label": "", "metadata": {}, "score": "58.005173"}
{"text": "PubMed View Article .Zelefsky MJ , Yamada Y , Fuks Z : Long - term results of conformal radiotherapy for prostate cancer : impact of dose escalation on biochemical tumor control and distant metastases - free survival outcomes .", "label": "", "metadata": {}, "score": "58.082245"}
{"text": "Patients were treated to total dose of 70 Gy in 28 daily fractional dose of 2.5 Gy .Biochemical failure , using both the ASTRO consensus definition [ 51 ] and the RTOG Phoenix definition ( nadir+2 ng / mL ) [ 52 ] , was the study endpoint .", "label": "", "metadata": {}, "score": "58.167587"}
{"text": "Biol .Med .Model .[ Google Scholar ] [ CrossRef ] .Schneider , U. ; Besserer , J. ; Mack , A. Hypofractionated radiotherapy has the potential for second cancer reduction .", "label": "", "metadata": {}, "score": "58.182915"}
{"text": "Acute toxicities were scored using the RTOG / EORTC criteria and the international prostate symptom index .None of the patients experienced grade 3 - 4 toxicity .", "label": "", "metadata": {}, "score": "58.18443"}
{"text": "ADVANTAGES Extensive lesions .Treating the disease in - situ .Avoid the surgical removal of tissue .To operate in accessible site .Choice of treatment for T1 and T2 tumors .", "label": "", "metadata": {}, "score": "58.277435"}
{"text": "The actuarial late RTOG grade 3 urinary toxicity rate at 5 years was 1 % .There were no grade 4 toxicities .Author 's Conclusions .", "label": "", "metadata": {}, "score": "58.324413"}
{"text": "67 - 74 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Zietman , K. Bae , J. D. Slater et al . , \" Randomized trial comparing conventional - dose with high - dose conformal radiation therapy in early - stage adenocarcinoma of the prostate : long - term results from Proton Radiation Oncology Group / American College Of Radiology 95 - 09 , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "58.33191"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Lian , J. ; Mackenzie , M. ; Joseph , K. ; Pervez , N. ; Dundas , G. ; Urtasun , R. ; Pearcey , R. Assesement of extended - field radiotherapy for stage IIIC endometrial cancer using three - dimensional conformal radiotherapy , intensity - modulated radiotherapy , and helical tomotherapy .", "label": "", "metadata": {}, "score": "58.36628"}
{"text": "Different works show that different quantitative in vivo endpoints are consistent with LQ model over a wide range of doses per fraction , including those of interest in hypofractionation [ 40 ] .", "label": "", "metadata": {}, "score": "58.40454"}
{"text": "This is the basic rationale for giving multiple smaller fractions of radiation per day instead of single daily dose .The require of minimum time is approximately 6 hours for normal tissue to repair .", "label": "", "metadata": {}, "score": "58.468422"}
{"text": "There was no statistically significant difference between these risk groups , indicating that all patients benefited equally .At this point , the potential advantage of short term androgen suppression for high - risk patients remains an issue of ongoing discussion as no corroborative evidence exclusive to this modality exists .", "label": "", "metadata": {}, "score": "58.60097"}
{"text": "Potters L , Morgenstern C , Calugaru E : 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer .J Urol 2005 , 173 : 1562 - 66 .", "label": "", "metadata": {}, "score": "58.701263"}
{"text": "There is a wide range between the fractions sizes used in these studies .Currently , the wide recognition of concurrent and adjuvant TMZ as the standard of care for GBM , diminishes somewhat the applicability of these previous studies to current treatment considerations .", "label": "", "metadata": {}, "score": "58.766567"}
{"text": "That study demonstrated that proton therapy reduced the risk of a secondary cancer by 26 - 39 % compared with IMRT .This reduction was attributed to the substantial sparing of the rectum and bladder from exposure to the therapeutic beam by proton therapy .", "label": "", "metadata": {}, "score": "58.782963"}
{"text": "Yoshioka Y , Nose T , Yoshida K , et al .High - Dose Rate Brachytherapy as Monotherapy for Localized Prostate Cancer : a Retrospective Analysis with Special Focus on Tolerance and Chronic Toxicity .", "label": "", "metadata": {}, "score": "58.84353"}
{"text": "Our treatment modality has also limitations .Intraprostatic calcifications may impair TRUS imaging quality thereby limiting real - time US - based treatment planning and dose conformality .", "label": "", "metadata": {}, "score": "58.89025"}
{"text": "[19 ] reported the preplanned interim safety analysis of randomized multicenter Conventional or Hypofractionated High - Dose Intensity - Modulated Radiotherapy for Prostate Cancer ( CH HiP ) trial .", "label": "", "metadata": {}, "score": "58.976517"}
{"text": "In fact , both for 3D - CRT and SBRT , the lesions were planned with the intent of providing the same target coverage and maintaining approximately the same tumor average dose .", "label": "", "metadata": {}, "score": "59.018303"}
{"text": "This method uses larger doses of radiation per fraction with fewer fractions total .The authors undertook a randomized trial at Fox Chase Cancer Center to evaluate the use of hypofractionated radiation ( 2.7 Gy / fraction ) versus conventional fractionation ( 2 Gy/ fraction ) .", "label": "", "metadata": {}, "score": "59.035408"}
{"text": "Table 2 : Prospective trials of hypofractionated external - beam radiotherapy ( 5 fractions ) .The first prospective trial of SBRT for prostate cancer was published by Madsen and colleagues [ 53 , 54 ] , who treated 40 patients with SBRT using a daily dose of 6.7 Gy to a total dose of 33.5 ( 6.7 Gy X 5 ) Gy .", "label": "", "metadata": {}, "score": "59.065678"}
{"text": "Approximately , three thousand patients , from the Radiation Therapy Oncology Group ( RTOG ) database , were examined .The median survival was found to be significantly greater in patients in whom RT was started more than 4 weeks from surgery .", "label": "", "metadata": {}, "score": "59.17903"}
{"text": "Clin .Med .Phys .[ Google Scholar ] .Hamamoto , Y. ; Kataoka , M. ; Yamashita , M. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions : In comparison with primary lung cancer .", "label": "", "metadata": {}, "score": "59.231873"}
{"text": "These models currently provide satisfactory estimates of solid tumor risk considering a population that received a single whole body exposure .Data from A - bomb survivors show that the risk of solid tumors for total body irradiation is linear up to about 2 Gy , reaching about 8 % [ 6 , 23 , 24 ] .", "label": "", "metadata": {}, "score": "59.255127"}
{"text": "You may notice that these side effects are similar to those described for conventionally fractionated radiation therapy - that 's because they are .In the end , it is still external beam radiation , and even the most precise delivery systems can not be free of side effects .", "label": "", "metadata": {}, "score": "59.26841"}
{"text": "Tumor integral dose was evaluated considering a standard \u03b1 / \u03b2 ratio of 10 Gy while the normalization of non - tumor integral doses were calculated assuming an \u03b1 / \u03b2 ratio of 3 Gy .", "label": "", "metadata": {}, "score": "59.28707"}
{"text": "All treatment plans were performed for a 6 MV Varian DBX Linac .Linear margins between multileaf collimator and PTV was 5 mm in order to have adequate target coverage .", "label": "", "metadata": {}, "score": "59.31001"}
{"text": "3 , no . 3 , pp .127 - 132 , 1991 .View at Google Scholar \u00b7 View at Scopus .T. Akimoto , H. Muramatsu , M. Takahashi et al . , \" Rectal bleeding after hypofractionated radiotherapy for prostate cancer : correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "59.32516"}
{"text": "Abbreviating the RT regimen can be clinically meaningful considering the life expectancy of patients with GBM .It is hoped that these advanced technologies can provide better quality of life , more convenient treatment options , and optimal utilization of the resources by health care providers .", "label": "", "metadata": {}, "score": "59.466564"}
{"text": "Conclusion .There is a growing body of compelling evidence supporting the safety and efficacy of abbreviated radiotherapy schedules for prostate cancer .Especially provocative are the recent reports of contemporary clinical trials that utilized the latest planning , imaging , and delivery techniques .", "label": "", "metadata": {}, "score": "59.475773"}
{"text": "[ 24 , 29 ] reported preliminary results of a multi - center phase I / II clinical trial that explored the increasingly hypofractionated radiation therapy for localized prostate cancer .", "label": "", "metadata": {}, "score": "59.479877"}
{"text": "62 - 66 , 2006 .View at Google Scholar \u00b7 View at Scopus .S. G. Williams , J. M. G. Taylor , N. Liu et al . , \" Use of individual fraction size data from 3756 patients to directly determine the \u03b1 / \u03b2 ratio of prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "59.485794"}
{"text": "The presence of a single case with a dose limiting toxicity required treating an additional three patients with dose level I and an additional dose limiting toxicity mandated dose reduction for all further patients to 51.4 Gy in19 fractions .", "label": "", "metadata": {}, "score": "59.55081"}
{"text": "This has been previously reported in patients with brain tumours [ 11 ] and because of which prophylaxis against this opportunistic infection was mandatory for all patients receiving TMZ in the EORTC / NCIC trial .", "label": "", "metadata": {}, "score": "59.578354"}
{"text": "Target volumes were slightly smaller in the hypofractionated arm .The treatment arms were well balanced with respect to T - category , Gleason score , pretreatment initial PSA , use of androgen deprivation therapy ( ADT ) and length of ADT .", "label": "", "metadata": {}, "score": "59.581985"}
{"text": "Thus , achieving similar clinical outcome while abbreviating treatment course can be of great clinical significance .An additional advantage to hypofractionation is the potential of improving tumour control .", "label": "", "metadata": {}, "score": "59.590687"}
{"text": "The incidence of acute grade 2 gastrointestinal and genitourinary toxicity was 36 % and 44 % , respectively .The authors compared these toxicity results with a historical control group treated with conventional radiotherapy fractionation and found that the hypofractionation group experienced greater grade 1 to 2 toxicity ( .", "label": "", "metadata": {}, "score": "59.715065"}
{"text": "Patients underwent CT simulation where all irradiated tissues were imaged using 0.3 cm thick slices .An MRI in the treatment position with the same immobilization device was also obtained and fused with the CT images .", "label": "", "metadata": {}, "score": "59.75226"}
{"text": "The repopulation parameter R in Equation ( 6 ) characterizes the repopulation / repairability of the tissue between two dose fractions .This approach was used for EAR assessment in SBRT .", "label": "", "metadata": {}, "score": "59.792976"}
{"text": "The PSA control rate was 90 % by the Phoenix definition .Tang et al .[ 55 ] used slightly higher dose per fraction ( 7 Gy ) to treat 30 men a phase I / II study .", "label": "", "metadata": {}, "score": "59.801594"}
{"text": "Phase II Prospective Study of the Use of Conformal High - Dose Rate Brachytherapy as Monotherapy for the Treatment of Favorable Stage Prostate Cancer : a Feasibility Report .", "label": "", "metadata": {}, "score": "59.83168"}
{"text": "No Grade 4 or higher acute or late toxicities occurred .Erectile dysfunction Grade 3 , defined as a medically assisted erectile dysfunction inadequate for intercourse , was reported by 19 ( 5.4 % ) patients prior to BRT .", "label": "", "metadata": {}, "score": "59.83983"}
{"text": "However , there was no difference in overall survival between the two arms .Acute genitourinary toxicity was higher in the hypofractionated arm with 9 % versus 5 % grade 3 or higher .", "label": "", "metadata": {}, "score": "59.85665"}
{"text": "This resulted in clustering of the majority of patients within one RPA class and due to our small sample size ; the effect of the RPA class could not be statistically appreciated .", "label": "", "metadata": {}, "score": "59.90159"}
{"text": "Differential DVHs for NTT and PTVs are reported in Figure 1 and Figure 2 for both techniques .The maximum treated volume was 86.1 cm 3 with a median volume of 33.2 cm 3 ( range between 1.5 cm 3 and 86.1 cm 3 ) .", "label": "", "metadata": {}, "score": "59.91761"}
{"text": "15 , pp .2020 - 2026 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer-(Pleneary Session ) , ASTRO , Miami , Fla , USA , 2011 . E. E. Yeoh , R. H. Holloway , R. J. Fraser et al . , \" Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma : updated results of a phase III randomized trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "59.958748"}
{"text": "877 - 882 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. M. McBride , D. S. Wong , J. J. Dombrowski et al . , \" Hypofractionated stereotactic body radiotherapy in low - risk prostate adenocarcinoma : preliminary results of a multi - institutional phase 1 feasibility trial , \" Cancer , vol .", "label": "", "metadata": {}, "score": "59.98453"}
{"text": "In our study , we used a dose escalation protocol to establish a safe and tolerable fractionation regimen and no late toxicity was reported with either dose levels .", "label": "", "metadata": {}, "score": "60.057907"}
{"text": "The 5-year rates of any failure for standard fractionation and hypofractionation were 14.4 % and 13.9 % , respectively .There were no statistically significant differences in GI toxicity between the arms .", "label": "", "metadata": {}, "score": "60.084366"}
{"text": "23 , no .25 , pp .6132- 6138 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , A. L. Hanlon , E. M. Horwitz et al . , \" Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "60.106926"}
{"text": "15 , pp .3681 - 3690 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. P. Boike , Y. Lotan , L. C. Cho et al . , \" Phase I dose - escalation study of stereotactic body radiation therapy for low- and intermediate - risk prostate cancer , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "60.21279"}
{"text": "4 , pp .1034 - 1039 , 1991 .View at Google Scholar \u00b7 View at Scopus .C. D. Collins , \" Radical external beam radiotherapy for localized carcinoma of the prostate using a hypofractionation technique , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "60.254387"}
{"text": "6 , pp .1133 - 1139 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Kuban , S. L. Tucker , L. Dong et al . , \" Long - term results of the M. D. Anderson randomized dose - escalation trial for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "60.279922"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Schneider , U. Mechanistic model of radiation - induced cancer after fractionated radiotherapy using the linear quadratic formula .", "label": "", "metadata": {}, "score": "60.350243"}
{"text": "As for the target , the same setup uncertainties for SBRT planning were considered for 3D - CRT .No margins were added for accounting ITV ( Internal Target Volume ) since the tumour volume was determined from 4D thoracic CT images , thus accounting for respiratory motion .", "label": "", "metadata": {}, "score": "60.402824"}
{"text": "5 , pp .756 - 759 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. J. Zelefsky , X. Pei , J. F. Chou et al . , \" Dose escalation for prostate cancer radiotherapy : predictors of long - term biochemical tumor control and distant metastases - free survival outcomes , \" European Urology , vol .", "label": "", "metadata": {}, "score": "60.413445"}
{"text": "According to a recent study , about 2,000 patients , representing about 20 % of the 10,000 prostate cancer patients receiving proton therapy from 1991 through 2010 believe that they made the best treatment decisions for themselves .", "label": "", "metadata": {}, "score": "60.42497"}
{"text": "The fractional dose in this trial was 2.75 Gy .Two hundred seventeen patients with T1 - 2 prostate carcinomas were randomized to either the standard or the hypofractionated arm between 1996 and 2006 .", "label": "", "metadata": {}, "score": "60.455254"}
{"text": "Attempting to phase these weaknesses , Brenner et al .[ 7 ] performed another post hoc analysis of a prospective dose escalation trial that combined external beam radiotherapy and HDR brachytherapy in men treated at a single institution .", "label": "", "metadata": {}, "score": "60.591278"}
{"text": "ratio is generally assumed to be approximately 10 Gy for most tumors and early - responding normal tissues and less than 5 Gy for late - responding tissues .", "label": "", "metadata": {}, "score": "60.70111"}
{"text": "PubMed View Article .Hess CF , Schaaf JC , Kortmann RD , Schabet M , Bamberg M : Malignant glioma : patterns of failure following individually tailored limited volume irradiation .", "label": "", "metadata": {}, "score": "60.833958"}
{"text": "The absence of any dose limiting toxicity , defined as an acute Grade 4 neurological radiation - induced toxicity within 30 days of starting radiation , in all of the 3 patients allowed moving into dose level II which was defined as 60 Gy in 22 fractions over 4.5 weeks .", "label": "", "metadata": {}, "score": "60.851128"}
{"text": "For the present study , D 3D - CRT was approximated to 64 Gy , delivered as 32 \u00d7 2 Gy fraction scheme .Conflict of Interest .", "label": "", "metadata": {}, "score": "60.91493"}
{"text": "In particular , a linear extrapolation of cancer risks from intermediate to very low doses appears to be the generally accepted methodology in ICRP [ 21 ] and BEIR [ 22 ] .", "label": "", "metadata": {}, "score": "60.923428"}
{"text": "Floyd et al .[ 2 ] , used a dose of 50 Gy at 5 Gy per fraction given to the enhancing primary tumour , residual disease or surgical cavity with a simultaneous dose of 30 Gy at 3 Gy per fraction to the surrounding oedema .", "label": "", "metadata": {}, "score": "60.94887"}
{"text": "At present it is generally agreed that around 10 % of patients may develop a second malignancy due to radiation therapy , even if this number is not known with much certainty and could range between 6 % and 13 % [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "60.959656"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. T. Pham , G. Song , K. Badiozamani , et al . , \" Five - year outcome of stereotactic hypofractionated accurate radiotherapy of the prostate ( SHARP ) for patients with low - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "60.989914"}
{"text": "The impact of thrombocytopenia was examined in a retrospective analysis of 52 consecutive patients with newly diagnosed high - grade gliomas treated with the Stupp protocol [ 12 ] .", "label": "", "metadata": {}, "score": "61.119843"}
{"text": "Despite the use of conformal RT , disease recurrence occurs in the treatment volume in the majority of patients [ 13 ] .The rate of recurrence outside the tumour bed is low and mostly occurs with or after recurrence of the original disease [ 14 ] .", "label": "", "metadata": {}, "score": "61.14196"}
{"text": "The rates of biochemical failure using the Nadir+2 ng / mL definition and clinical failure , consisting of either local - regional failure or distant metastasis ( LRF / DM ) , and deaths without failure were reported .", "label": "", "metadata": {}, "score": "61.238953"}
{"text": "UCLA index data showed a slight improvement in urinary function at 2 years compared with pretreatment .LENT / SOMA assessments demonstrated worsening of bowel function at 2 years .", "label": "", "metadata": {}, "score": "61.303116"}
{"text": "[ Google Scholar ] [ CrossRef ] .Ruben , J.D. ; Davis , S. ; Evans , C. ; Jones , P. ; Gagliardi , F. ; Haynes , M. ; Hunter , A. The effect of intensity - modulated radiotherapy on radiation - induced second malignancies .", "label": "", "metadata": {}, "score": "61.312508"}
{"text": "The RPA class is one of the most significant prognostic factors that determine survival in patients with GBM .This has also been shown to hold true in the era of concurrent RT and TMZ ( 18 ) .", "label": "", "metadata": {}, "score": "61.36045"}
{"text": "Prostate and organs at risk ( OAR , i.e. , rectum , urethra , bladder ) contouring was checked and updated according to the new acquired image set .", "label": "", "metadata": {}, "score": "61.37424"}
{"text": "[16 ] reported the incidence of pseudoprogression among 103 patients treated with TMZ concurrent with and adjuvant to RT .Out of 50 patients who developed radiological progression as assessed by MRI done 4 weeks after treatment completion , 32 ( 64 % ) were identified to have pseudoprogression .", "label": "", "metadata": {}, "score": "61.388268"}
{"text": "Pollack et al .[14 ] reported results of a hypofractionated trial in patients with intermediate to high - risk features .The fractional dose was 2.7 Gy per treatment .", "label": "", "metadata": {}, "score": "61.42199"}
{"text": "78 - 81 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Ritter , J. D. Forman , and D. G. Petereit , \" Dose - per - fraction escalation for localized prostate cancer : a multi - institutional phase I / II Trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "61.551117"}
{"text": "56 , no .4 , pp .1093 - 1104 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. J. Brenner , \" The linear - quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction , \" Seminars in Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "61.56144"}
{"text": "There were no statistically significant differences in late toxicity between the 2 arms .The incidence of late grade 3 or higher genitourinary or gastrointestinal toxicity was 1 % and 2 % , respectively .", "label": "", "metadata": {}, "score": "61.57556"}
{"text": "PubMed View Article .Brandes AA , Franceschi E , Tosoni A , Blatt V , Pession A , Tallini G , et al .: MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients .", "label": "", "metadata": {}, "score": "61.578503"}
{"text": "Patients received androgen suppression for 3 - 6 months before and during radiotherapy , but it was optional for men with low - risk disease .", "label": "", "metadata": {}, "score": "61.591377"}
{"text": "2 ng / mL definition .These results compare favourably to those achieved in patients contemporaneously treated with conventional fractionation at the Cleveland Clinic ( 78 Gy at 2 Gy / fraction ) .", "label": "", "metadata": {}, "score": "61.63702"}
{"text": "The use of IMRT , HT in particular , is thought to physically allow dose escalation while keeping reasonable dose constraints to at risk normal tissue .", "label": "", "metadata": {}, "score": "61.682167"}
{"text": "All the cases of disease recurrence were either local or marginal i.e. within 2 cm of the tumour bed .Nine patients progressed within three months of the completion of RT .", "label": "", "metadata": {}, "score": "61.697704"}
{"text": "Prospective Randomized Clinical Trials Comparing Different Radiation Regimens .Two randomized , controlled trials that have been published compared radiation regimens with different daily fraction sizes in patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "61.701447"}
{"text": "Length of ADT did not impact GU toxicity .Author 's Conclusions .With a median follow up of greater than 5 years , the efficacy of hypofractionated IMRT for the treatment of prostate cancer appears to be equivalent to conventional IMRT in this randomized trial at Fox Chase Cancer Center .", "label": "", "metadata": {}, "score": "61.799347"}
{"text": "A future report will include mature biochemical control rates data .One hundred sixty - eight patients were randomized to receive three - dimensional conformal radiotherapy to the prostate and seminal vesicles .", "label": "", "metadata": {}, "score": "61.828033"}
{"text": "In our study , delays greater than 6 weeks in initiating RT adversely affected outcome .The influence of delaying RT could have been potentiated by the presence of considerable proportion ( 36 % ) of patients who only had a biopsy for a tumour notorious for its short doubling time .", "label": "", "metadata": {}, "score": "61.8518"}
{"text": "Seven ( 1.9 % ) patients developed late Grade 3 urinary retention requiring urethrotomy for urethral strictures .Another four ( 1.1 % ) patients developed late Grade 3 gastrointestinal toxicity , two of whom had endoscopically verified Grade 3 rectal mucositis .", "label": "", "metadata": {}, "score": "61.886795"}
{"text": "[26 ] .The authors of this trial compared a conventionally fractionated regimen ( 2 Gy / fraction to 64 Gy ) with a hypofractionated regimen ( 2.75 Gy / fraction to 55 Gy ) .", "label": "", "metadata": {}, "score": "62.04425"}
{"text": "This suggests that integral dose is not a good estimator for quantifying cancer induction .Indeed , for the model and parameters used , hypofractionated radiotherapy has the potential for secondary cancer reduction .", "label": "", "metadata": {}, "score": "62.053127"}
{"text": "PubMed View Article .Garden AS , Maor MH , Yung WK , Bruner JM , Woo SY , Moser RP , et al .: Outcome and patterns of failure following limited - volume irradiation for malignant astrocytomas .", "label": "", "metadata": {}, "score": "62.090477"}
{"text": "It enables 3D anatomy - based optimisation of the dose distribution by accurately controlling the radiation source positioning and modulating source dwell times .This permits excellent target coverage while at the same time minimizing dose to critical structures which can occur with LDR BRT due to source migration and tissue deformities [ 25 ] .", "label": "", "metadata": {}, "score": "62.10397"}
{"text": "Results from several clinical studies of hypofractionated radiotherapy , especially with IMRT , have found that late gastrointestinal and genitourinary toxicity is well tolerated .Another potential benefit of hypofractionated radiotherapy is reduction in treatment cost and shortening of waiting lists in high - volume radiotherapy departments .", "label": "", "metadata": {}, "score": "62.110832"}
{"text": "PubMed View Article .Skazikis G , Kurek R , Baltas D : Acute toxicity of HDR - brachytherapy as monotherapy for low - risk cancer : Analysis of 297 patients treated with two different fractionation schemes .", "label": "", "metadata": {}, "score": "62.12442"}
{"text": "One of the early experiences using hypofractionation for prostate cancer came from Europe .Over 200 patients were treated at St. Thomas Hospital in London with hypofractionated radiotherapy to a dose of 55 Gy in 12 fractions and later to doses of 36 Gy in 6 fractions with low rectal and urological complications [ 39 , 40 ] .", "label": "", "metadata": {}, "score": "62.175797"}
{"text": "Response to treatment was classified according to the RECIST criteria .The primary endpoints were feasibility and safety of Hypo - IMRT with concurrent TMZ .", "label": "", "metadata": {}, "score": "62.176235"}
{"text": "In this study , for all treatment plans integral dose was calculated through the differential DVH using Equation ( 1 ) .By changing the fractionation scheme of a certain treatment plan , the ID also changes .", "label": "", "metadata": {}, "score": "62.202126"}
{"text": "Phys .[ Google Scholar ] [ CrossRef ] .Uematsu , M. ; Shioda , A. ; Suda , A. ; Fukui , T. ; Ozeki , Y. ; Hama , Y. ; Wong , J.R. ; Kusano , S. Computer tomography guided frameless stereotactic radiotherapy for stage I nonsmall cell lung cancer : A 5 year experience .", "label": "", "metadata": {}, "score": "62.228012"}
{"text": "PubMed View Article .Gerber DE , Grossman SA , Zeltzman M , Parisi MA , Kleinberg L : The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high - grade gliomas .", "label": "", "metadata": {}, "score": "62.30766"}
{"text": "Final decisions concerning hormonal treatment were made by the referring urologists .Patient and tumour characteristics are shown in Table 1 .Brachytherapy protocol .Transperineal implantation was performed under TRUS guidance using a continuous probe movement technique [ 19 ] .", "label": "", "metadata": {}, "score": "62.36918"}
{"text": "[ 8 ] , Hoskin et al .[ 3 ] and Yoshioka et al .[ 2 ] likewise failed to verify Gleason score and pre - treatment PSA or clinical stage as significant predictors of risk of biochemical failure .", "label": "", "metadata": {}, "score": "62.37702"}
{"text": "203 - 210 , 1993 .View at Google Scholar \u00b7 View at Scopus .G. Read and R. C. S. Poiton , \" Retrospective study of radiotherapy in early carcinoma of the prostate , \" British Journal of Urology , vol .", "label": "", "metadata": {}, "score": "62.461075"}
{"text": "43 , pp .370 - 381 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Katz , M. Santoro , F. DiBlasio , et al . , \" Stereotactic body radiation therapy for low , intermediate , and high - risk prostate cancer : disease control and quality of life , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.475548"}
{"text": "5 , pp .473 - 477 , 2010 .View at Google Scholar \u00b7 View at Scopus .J. L. Friedland , D. E. Freeman , M. E. Masterson - McGary , and D. M. Spellberg , \" Stereotactic body radiotherapy : an emerging treatment approach for localized prostate cancer , \" Technology in Cancer Research and Treatment , vol . 8 , no .", "label": "", "metadata": {}, "score": "62.50334"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Hall , E.J. ; Wuu , C.-S. Radiation - induced second cancers : The impact of 3D - CRT and IMRT .", "label": "", "metadata": {}, "score": "62.544827"}
{"text": "5 , pp .545 - 554 , 1995 .View at Google Scholar \u00b7 View at Scopus .C. D. Collins , R. W. Lloyd - Davies , and A. V. Swan , \" Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "62.60631"}
{"text": "This factor could not be assessed in our study as MGMT methylation was unfortunately not tested in our patients .The incidence of pseudoprogression has been variably reported in the literature .", "label": "", "metadata": {}, "score": "62.61373"}
{"text": "However , there were no statistically significant changes in AUA scores or EPIC Urinary scores .In addition to the progressively larger dose per fraction used in the previously mentioned clinical studies , researchers at University of Texas at Southwestern Medical Center at Dallas ( UTSW ) conducted an animal experiment using higher doses per fraction .", "label": "", "metadata": {}, "score": "62.619514"}
{"text": "15 , no . 1 , pp . 1 - 6 , 2009 .View at Google Scholar \u00b7 View at Scopus .M. Carlone , D. Wilkins , B. Nyiri , and P. Raaphorst , \" Comparison of \u03b1 / \u03b2 estimates from homogeneous ( individual ) and heterogeneous ( population ) tumor control models for early stage prostate cancer , \" Medical Physics , vol .", "label": "", "metadata": {}, "score": "62.737843"}
{"text": "381 - 385 , 1993 .View at Google Scholar \u00b7 View at Scopus .C. Park , L. Papiez , S. Zhang , M. Story , and R. D. Timmerman , \" Universal survival curve and single fraction equivalent dose : useful tools in understanding potency of ablative radiotherapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.745083"}
{"text": "Androgen deprivation was allowed .Patients were stratified by Gleason score , PSA , and use of long term androgen deprivation therapy use .Primary endpoint included the ASTRO Biochemical Failure ( BF ) definition of 3 consecutive rises as well as Nadir+2 ng / mL definition and salvage therapy prior to biochemical failure .", "label": "", "metadata": {}, "score": "62.75986"}
{"text": "For intermediate stage radiation therapy used as an adjuvant role to surgery .For advanced tumors radiation therapy is extensively used .The success of radiation therapy as a treatment modality depends on differences in repair capabilities between normal & malignant cells .", "label": "", "metadata": {}, "score": "62.838417"}
{"text": "PubMed View Article .Sultanem K , Patrocinio H , Lambert C , Corns R , Leblanc R , Parker W , et al .: The use of hypofractionated intensity - modulated irradiation in the treatment of glioblastoma multiforme : preliminary results of a prospective trial .", "label": "", "metadata": {}, "score": "62.85961"}
{"text": "With regard to acute toxicity , two patients in our study developed Grade 3 - 4 myelosuppression which is expected given the toxicity profile reported in the EORTC / NCIC trial [ 1 ] .", "label": "", "metadata": {}, "score": "62.866455"}
{"text": "387 - 392 , 2009 .View at Google Scholar \u00b7 View at Scopus .S. Jabbari , V. K. Weinberg , T. Kaprealian et al . , \" Stereotactic body radiotherapy as monotherapy or post - external beam radiotherapy boost for prostate cancer : technique , early toxicity , and PSA response , \" International Journal of Radiation Oncology , Biology , Physics , vol .", "label": "", "metadata": {}, "score": "62.898834"}
{"text": "Most reports document a drop in the PSA after treatment with Cyberknife , however the follow - up is shorter than the follow - up in studies of conventionally fractioned radiotherapy since this treatment technique is relatively new .", "label": "", "metadata": {}, "score": "62.913033"}
{"text": "( a )Three - dimensional reconstruction of the prostate , organs at risk ( i.e. , rectum , urethra , bladder ) , in situ needles and the intraprostatic source dwell positions as calculated using SWIFT for the final treatment plan .", "label": "", "metadata": {}, "score": "62.91357"}
{"text": "While the patient is being treated , cameras take images of the tumor , which are then compared to the images from the CT simulation .", "label": "", "metadata": {}, "score": "62.914528"}
{"text": "Introduction .Prostate cancer is the most common cancer diagnosed in American men after non - melanomatous skin cancer .According to the American Cancer Society estimate , there will be more than 241,000 new cases of prostate cancer in the United States in 2012 .", "label": "", "metadata": {}, "score": "62.935715"}
{"text": "Biol .Med .Model .[ Google Scholar ] [ CrossRef ] .Med .Phys .[ Google Scholar ] .Petti , P.L. ; Chuang , C.F. ; Smith , V. ; Larson , D.A. Peripheral doses in CyberKniferadiosurgery .", "label": "", "metadata": {}, "score": "62.96371"}
{"text": "In fact , A - bomb survivors received a single dose exposure of radiation , whereas radiotherapy patients receive fractionated therapy over an extended period , thus allowing for some repair of DNA damage .", "label": "", "metadata": {}, "score": "63.058395"}
{"text": "Maturation of these trials and others in development will help to answer several key questions , including the confirmation of the expected improvement in the therapeutic ratio , long - term biochemical relapse free survival , and long - term quality - of - life parameters .", "label": "", "metadata": {}, "score": "63.060753"}
{"text": "Recently , Panet - Raymond et al .[ 4 ] retrospectively studied the feasibility of delivering Hypo - IMRT with concurrent and adjuvant TMZ on a cohort of 35 patients .", "label": "", "metadata": {}, "score": "63.09408"}
{"text": "847 - 852 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. Kirkpatrick , J. J. Meyer , and L. B. Marks , \" The linear - quadratic model is inappropriate to model high dose per fraction effects in radiosurgery , \" Seminars in Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "63.17769"}
{"text": "Environ .Biophys .[ Google Scholar ] [ CrossRef ] .Schneider , U. ; Zwahlen , D. ; Ross , D. ; Kaser - Hotz , B. Estimation of radiation - induced cancer from three - dimensional dose distributions : Concepts of organ equivalent dose .", "label": "", "metadata": {}, "score": "63.255775"}
{"text": "Further assessments of integral doses received with 3D - CRT and other special techniques are also strongly encouraged .Keywords : . stereotactic body radiation therapy ; integral dose ; linear - quadratic model ; biologically effective dose ; BED ; radio - induced secondary malignancies .", "label": "", "metadata": {}, "score": "63.29588"}
{"text": "PubMed View Article .Brandes AA , Tosoni A , Franceschi E , Sotti G , Frezza G , Amista P , et al .: Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma : correlation With MGMT promoter methylation status .", "label": "", "metadata": {}, "score": "63.297424"}
{"text": "International Journal of Radiation Oncology Biology Physics , vol .56 , no .4 , pp .1093 - 1104 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Loblaw and P. Cheung , \" External beam irradiation for localized prostate cancer - the promise of hypofractionation , \" The Canadian Journal of Urology , vol .", "label": "", "metadata": {}, "score": "63.33997"}
{"text": "The study included 36 patients treated with 56 Gy in 16 fractions ( 3.5 Gy per fraction ) over 4 weeks , 4 fractions per week , using 3-dimentional conformal radiation therapy or IMRT .", "label": "", "metadata": {}, "score": "63.386692"}
{"text": "Routine implementation of IMRT with tight PTV margins and IGRT are likely to have contributed to reduce the treatment - related toxicities .A recently completed RTOG 0415 Phase III trial assigned randomized patients to either the hypofractionation treatment strategy from the report by Kupelian et al .", "label": "", "metadata": {}, "score": "63.610676"}
{"text": "43 - 54 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Arcangeli , B. Saracino , S. Gomellini et al . , \" A Prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "63.73651"}
{"text": "At 5 years , the rectal and urinary toxicities reported are acceptable .An advantage for the patient is a decreased overall treatment time .The challenge then is to determine the optimal fractionation schedule that will give excellent disease control while limiting treatment toxicities .", "label": "", "metadata": {}, "score": "63.88131"}
{"text": "The planning objective was to deliver the specified dose to at least 95 % of the PTV while minimizing the dose to the defined OAR .", "label": "", "metadata": {}, "score": "63.88741"}
{"text": "Xu , X.G. ; Bednarz , B. ; Paganetti , H. A review of dosimetry studies on external - beam radiation treatment with respect to second cancer induction .", "label": "", "metadata": {}, "score": "63.93102"}
{"text": "In particular , note the additional unnecessary radiation dose to the rectum in the right side pictures .Proton therapy for prostate cancer treatment reduces the risk of secondary cancers in addition to reducing debilitating side effects such as impotence and incontinence - A crucial advantage for the use of proton therapy for prostate cancer is conveniently ignored by the commercial payers and article authors .", "label": "", "metadata": {}, "score": "63.94095"}
{"text": "Nevertheless , possible dosimetric inaccuracies are likely to affect DVH calculations ( and the following DVH - related evaluations ) in both TPS in the same magnitude .", "label": "", "metadata": {}, "score": "63.99811"}
{"text": "Criteria for a satisfactory treatment delivery include a point dose measurement , taken in a high dose and low gradient region within 2 % of the calculated dose and gamma index with a distance to agreement goal of 3 mm and a percent dose difference goal of 5 % .", "label": "", "metadata": {}, "score": "64.03954"}
{"text": "Given the very encouraging results with the SBRT technique , phase III studies are in fact strongly needed in order to compare SBRT with surgery in operable patients [ 17 ] .", "label": "", "metadata": {}, "score": "64.09878"}
{"text": "4 , pp .240 - 243 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. W. Lloyd - Davies , C. D. Collins , and A. V. Swan , \" Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation .", "label": "", "metadata": {}, "score": "64.12699"}
{"text": "The authors observed differences in toxicity depending on the treatment regimen .More specifically , acute rectal toxicity was worse in the hypofractionated arm , while late urinary and rectal toxicity were reported as equivalent but were not quantified .", "label": "", "metadata": {}, "score": "64.23163"}
{"text": "The ASTRO biochemical failure definition ( A - bRFS ) as well as the alternate nadir +2ng / ml definition ( N - bRFS ) were evaluated .", "label": "", "metadata": {}, "score": "64.23406"}
{"text": "In the final questionnaire 293 patients ( 83.4 % ) reported an erection adequate for intercourse achieved with or without the use of erectile aids .", "label": "", "metadata": {}, "score": "64.26289"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Pirzkall , A. ; Lohr , F. ; H\u00f6ss , A. ; Wannenmacher , M. ; Debus , J. Comparison of intensity modulated radiotherapy with conventional conformal radiotherapy for complex - shaped tumors .", "label": "", "metadata": {}, "score": "64.27583"}
{"text": "The reason is that the tumor cell response , proportional to the BED as determined in the equation above , is generally less influenced by fraction size than is the BED for the late - responding normal tissues that surround the targeted tumor .", "label": "", "metadata": {}, "score": "64.29146"}
{"text": "Recurrences outside the treatment field were observed in 20 % of the patients .Furthermore , there was a significant higher survival rate in patients with recurrence outside the RT fields ( median survival of 26.1 months vs. 17.3 months ) .", "label": "", "metadata": {}, "score": "64.35053"}
{"text": "According to the same work , number of beams , beam direction and relative beam weight have little effect on NTID .When evaluating radiation dose to healthy tissues , especially at sites remote from the treatment region , radiation leakage may represent an important factor , increasing integral dose to normal structures .", "label": "", "metadata": {}, "score": "64.3734"}
{"text": "The use of IMRT is considered to allow selective delivery of high dose per fraction to the target volume while maintaining the dose to surrounding normal tissues below certain threshold doses [ 2 ] .", "label": "", "metadata": {}, "score": "64.3757"}
{"text": "All of the patients received Trimethoprim - Sulfamethoxazole for prophylaxis against Pneumocystis jiroveci pneumonia .Patient assessment and outcome .In this phase I study , patients were assessed weekly during RT with clinical examination , Karnofsky performance status , complete blood counts , renal function tests and liver enzymes .", "label": "", "metadata": {}, "score": "64.41186"}
{"text": "With over 200,000 men diagnosed annually with prostate cancer in the United States even a small incidence of secondary cancers would result in a significant number of men developing secondary cancers .", "label": "", "metadata": {}, "score": "64.49823"}
{"text": "Morbidity was measured with the LENT - SOMA questionnaires .Gastrointestinal and genitourinary toxicity did not differ significantly between fractionation schedules .Investigators found that the conventional fractionation independently predicted for worse biochemical failure and genitourinary symptoms at 4 years .", "label": "", "metadata": {}, "score": "64.570755"}
{"text": "Stupp R , Mason WP , van den Bent MJ , Weller M , Fisher B , Taphoorn MJ , et al .: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma .", "label": "", "metadata": {}, "score": "64.68733"}
{"text": "6 , pp .469 - 475 , 2009 .View at Google Scholar \u00b7 View at Scopus .G. Soete , S. Arcangeli , G. De Meerleer et al . , \" Phase II study of a four - week hypofractionated external beam radiotherapy regimen for prostate cancer : report on acute toxicity , \" Radiotherapy and Oncology , vol .", "label": "", "metadata": {}, "score": "64.70398"}
{"text": "[ 27 , 28 , 29 , 30 ] for predicting cancer induction after radiotherapy , therefore including fractionation effects .The model is based on the linear - quadratic formalism , where inductions of carcinomas and sarcomas are modeled separately and described in terms of analytical functions .", "label": "", "metadata": {}, "score": "64.72969"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Karlsson , P. ; Holmberg , E. ; Samuelsson , A. ; Johansson , K.-A. ; Wallgren , A. Soft tissue sarcoma after treatment for breast cancer - A Swedish population - based study .", "label": "", "metadata": {}, "score": "64.741165"}
{"text": "1043 - 1048 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. R. King , J. D. Brooks , H. Gill , and J. C. Presti Jr. , \" Long - term outcomes from a prospective trial of stereotactic body radiotherapy for low - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "64.84729"}
{"text": "[ 15 ] has recently reported the pattern of failure in 95 patients with newly diagnosed GBM treated with radiotherapy plus concomitant and adjuvant TMZ .", "label": "", "metadata": {}, "score": "64.85843"}
{"text": "Milickovic N , Mavroidis P , Tselis N : 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U / S - based prostate HDR brachytherapy treatment delivery .", "label": "", "metadata": {}, "score": "64.907974"}
{"text": "Kupelian et al .[20 ] at the Cleveland Clinic were among the first that combined improvements in radiotherapy technology with the low .ratio hypothesis in order to examine a hypofractionated regimen in a controlled phase I / II clinical trial .", "label": "", "metadata": {}, "score": "64.988304"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Schneider , U. ; Kaser - Hotz , B. Radiation risk estimates after radiotherapy : Applications of the organ equivalent dose concept to plateau dose - response relationships .", "label": "", "metadata": {}, "score": "65.23337"}
{"text": "1200 - 1207 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Fowler , M. A. Ritter , R. J. Chappell , and D. J. Brenner , \" What hypofractionated protocols should be tested for prostate cancer ? \"", "label": "", "metadata": {}, "score": "65.294876"}
{"text": "The acute rectal toxicity rate ( grade 1 - 2 ) was 80 % , while the acute urinary toxicity rate ( grade 1 - 2 ) was 91 % .", "label": "", "metadata": {}, "score": "65.30093"}
{"text": "518 - 526 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , G. Walker , and M. Buyyounouski , \" Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "65.30134"}
{"text": "Over the last decade integral dose has aroused a lively interest due to its alleged correlation with secondary cancers .Radiation - induced secondary malignancies are rare , but since treatment techniques improve and clinical outcomes are improving accordingly , secondary tumor risk after oncologic treatment might represent a relevant issue .", "label": "", "metadata": {}, "score": "65.305176"}
{"text": "Martin et al .[ 18 ] reported a prospective Phase II trial also using 3 Gy per fraction to treat 92 patients between 2001 and 2004 .", "label": "", "metadata": {}, "score": "65.396164"}
{"text": "In the past , different authors have used the dose - response relationship for A - bomb survivors to assess induced secondary cancers in radiation therapy by applying a correction dose - rate effectiveness factor ( DREF ) to take into account exposure to different doses and dose rates [ 6 , 26 ] .", "label": "", "metadata": {}, "score": "65.409454"}
{"text": "Freeman D and King C. Stereotactic body radiotherapy for low - risk prostate cancer : five - year outcomes .Rad Onc 6:3 , 2011 .", "label": "", "metadata": {}, "score": "65.418976"}
{"text": "191 - 195 , 1989 .View at Google Scholar \u00b7 View at Scopus . K. Haustermans and J. F. Fowler , \" A comment on proliferation rates in human prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "65.42855"}
{"text": "24 - 33 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. L. Scrivner , J. S. Meyer , N. Rujanavech , A. Fathman , and T. Scully , \" Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies , \" Journal of Urology , vol .", "label": "", "metadata": {}, "score": "65.44966"}
{"text": "J. Clin .Oncol .[ Google Scholar ] [ CrossRef ] .Ekstrand , K.E. ; Barnes , W.H. Pitfalls in the use of high energy x - rays to treat tumours in the lung .", "label": "", "metadata": {}, "score": "65.49216"}
{"text": "Loss of remineralization , loss of buffering capacity , gingival third and the incisal cusp tips - caries .TREATMENT Fluorides , occlusive splints , chlorhexidine gel 2 % .", "label": "", "metadata": {}, "score": "65.61414"}
{"text": "PubMed View Article .Sanghera P , Perry J , Sahgal A , Symons S , Aviv R , Morrison M , et al .: Pseudoprogression following chemoradiotherapy for glioblastoma multiforme .", "label": "", "metadata": {}, "score": "65.65054"}
{"text": "These regimens were designed to maintain equivalent predicted late toxicity of approximately 76 Gy in 38 fractions .When the tumor . of 1.5 Gy is assumed , the 2 Gy equivalent dose is estimated to be 82 Gy .", "label": "", "metadata": {}, "score": "65.66932"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Fowler , M. A. Ritter , J. D. Fenwick , and R. J. Chappell , \" How low is the \u03b1 / \u03b2 ratio for prostate cancer ?", "label": "", "metadata": {}, "score": "65.683136"}
{"text": "This study revealed very low rates of late GI toxicity with no grade 3 toxicity seen .There were higher rates of GU toxicity seen in the hypofractionated arm ; however , these toxicities were very closely associated with pre - treatment AUA and were rarely repeated .", "label": "", "metadata": {}, "score": "65.68984"}
{"text": "78 - 81 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Ritter , J. D. Forman , P. A. Kupelian , et al . , \" A phase I / II trial of increasingly hypofractionated radiation therapy for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "65.709305"}
{"text": "Results .There were a total of 61 failures by the ASTRO definition of biochemical failure .There were no differences in any endpoint between the two arms in terms of efficacy of treatment for prostate cancer .", "label": "", "metadata": {}, "score": "65.75469"}
{"text": "At median follow - up of 2.7 years , there were no grade 4 toxicities .RTOG grade 3 , 2 , and 1 bladder toxicities were seen in 3 % ( 2 patients ) , 5 % ( 3 patients ) , and 23 % ( 13 patients ) , respectively .", "label": "", "metadata": {}, "score": "65.75927"}
{"text": "Stereotactic Body Radiation Therapy for Prostate Cancer .Stereotactic Body Radiation Therapy ( SBRT ) involves an ultra - abbreviated treatment regimen of 5 or fewer fractions administered using image guidance and precise treatment delivery techniques .", "label": "", "metadata": {}, "score": "65.79791"}
{"text": "ratio of 1.5 .The trial compared 76 Gy in conventional 2.0 Gy fractions to 70.2 Gy in 2.7 Gy fractions .The hypofractionated arm was estimated to be equivalent to 84.4 Gy in 2.0 Gy fractions and designed to be equivalent to 8 Gy increase over the standard fractionated total dose of 76 Gy .", "label": "", "metadata": {}, "score": "65.80312"}
{"text": "The planning target volume ( PTV ) was defined as the entire prostate gland without margins .Based on the acquired 3D anatomy , the appropriate virtual needle positions were generated using the intraoperative treatment planning system SWIFT ( Nucletron B.V. , Veenendaal , The Netherlands ) .", "label": "", "metadata": {}, "score": "65.81251"}
{"text": "The objective of the trial primary endpoint was a comparison preliminary report focused on early toxicity using the RTOG / European Organization for Research and Treatment of Cancer ( EORTC ) acute toxicity grading system .", "label": "", "metadata": {}, "score": "65.94288"}
{"text": "Dose volume histograms ( DVHs ) for prostate , urethra , and rectum were calculated for evaluation of the anatomy - based dose optimisation .As the preplanning dosimetry parameters fulfilled our dosimetric protocol ( Table 2 ) , TRUS guided implantation of steel needles ( 200 mm length , 1.9 mm diameter ) was performed at the previously determined positions .", "label": "", "metadata": {}, "score": "66.04135"}
{"text": "4 , pp .943 - 955 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Arcangeli , B. Saracino , S. Gomellini et al . , \" A Prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "66.188126"}
{"text": "With the median follow - up of 44.5 months , none of the patients experience biochemical failure by Phoenix ( nadir+2 ) definition .Thirteen patients experienced PSA bounces .", "label": "", "metadata": {}, "score": "66.22491"}
{"text": "Potency was defined as the ability to achieve an erection that was sufficient for intercourse .The estimated likelihood of events was calculated using the Kaplan - Meier method and comparisons made using the log - rank test .", "label": "", "metadata": {}, "score": "66.31397"}
{"text": "In the present paper we used a dose - response relationship for cancer induction that includes fractionation effects , therefore suitable for radiotherapy applications .Under the assumptions made and according to the model used our study indicates that despite the fact that for all patients integral dose is higher for SBRT treatments than 3D - CRT , secondary cancer risk associated to SBRT patients is significantly smaller than that calculated for 3D - CRT .", "label": "", "metadata": {}, "score": "66.33638"}
{"text": "There is great uncertainty regarding the dose - response relationship for induced secondary cancers in radiation therapy [ 18 , 19 , 20 ] .Currently , no accurate risk model exists and some approximations are unavoidably necessary to model data .", "label": "", "metadata": {}, "score": "66.40034"}
{"text": "Three patients developed pathologically confirmed extensive necrosis .One was treated at level 1 , one at level 2 and the third at level 4 .", "label": "", "metadata": {}, "score": "66.40598"}
{"text": "Kaplan - Meier actuarial analysis of all 351 patients for : ( a ) Biochemical control , overall survival and metastasis - free survival and ( b ) Biochemical control by risk group .", "label": "", "metadata": {}, "score": "66.44082"}
{"text": "All patients were treated with a minimum of 36 hours between fractions with no more than 3 fractions per week .At the time of the report , the median follow - up was 30 months , 18 months , and 12 months for the 45 Gy , 47.5 Gy , and 50 Gy groups , respectively .", "label": "", "metadata": {}, "score": "66.54239"}
{"text": "CT slice thickness was 2.5 mm in all patients .For both techniques , OARs , PTV and Body minus PTV were then contoured by an experienced radiation oncologist .", "label": "", "metadata": {}, "score": "66.59625"}
{"text": "The choice of these values was inevitably arbitrary since the \u03b1 / \u03b2 concept is a non - stochastic concept referring to cell killing and at present it is not known which \u03b1 / \u03b2 value might be related to a stochastic effect as the induction of tumors .", "label": "", "metadata": {}, "score": "66.62408"}
{"text": "Seventy six percent of the treated cohort received adjuvant TMZ but only 48 % of the patients completed 3 or more cycles .Of the patients who failed to complete 6 cycles of adjuvant TMZ , 14 of them were due to disease progression .", "label": "", "metadata": {}, "score": "66.63962"}
{"text": "While we acknowledge that proton therapy is currently more expensive than Intensity Modulated Radiation Therapy ( IMRT ) , this can be negated by the use of hypo - fractionation .", "label": "", "metadata": {}, "score": "66.666626"}
{"text": "4 , pp .1153 - 1160 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Soete , S. Arcangeli , G. De Meerleer et al . , \" Phase II study of a four - week hypofractionated external beam radiotherapy regimen for prostate cancer : report on acute toxicity , \" Radiotherapy and Oncology , vol .", "label": "", "metadata": {}, "score": "66.698265"}
{"text": "Int .J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Herman , T.D.L.F. ; Vlachaki , M.T. ; Herman , T.S. ; Hibbitts , K. ; Stoner , J.A. ; Ahmad , S. Stereotactic body radiation therapy ( SBRT ) and respiratory gating in lung cancer : Dosimetric and radiobiological considerations .", "label": "", "metadata": {}, "score": "66.73992"}
{"text": "For the present study , the total 3D - CRT dose was approximated to 64 Gy , delivered as 32 \u00d7 2 Gy fraction scheme ( Appendix ) .", "label": "", "metadata": {}, "score": "66.75018"}
{"text": "Mortality , 1950 - 1985 : Part 2 .Cancer mortality based on the recently revised doses ( DS86 ) .Radiat .Res .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "66.78952"}
{"text": "Out of 101 evaluable patients , 9 % experienced late grade 2 urinary toxicity , and 1 % experienced late grade 3 urinary toxicity .The authors reported no grade 3 rectal toxicity .", "label": "", "metadata": {}, "score": "66.814285"}
{"text": "It is worth noting that the results presented in this study are valid under the assumptions made : neither neutron dose nor leakage radiation accounted and risk calculations performed on the plane of interest for the treatment .", "label": "", "metadata": {}, "score": "66.90799"}
{"text": "The median number of adjuvant TMZ cycles was 2 and in the EORTC / NCIC trial , the median number was 3 .However , due to the small sample size of our study , it is difficult to conclude whether the intensified radiation dose could have reduced the patients ' tolerance to adjuvant TMZ .", "label": "", "metadata": {}, "score": "66.92587"}
{"text": "1106 - 1111 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. D. Thames and H. D. Suit , \" Tumor radioresponsiveness versus fractionation sensitivity , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "66.92971"}
{"text": "At present , the LQ model is reasonably well validated ( experimentally and theoretically ) and its use is reasonable up to several Grays per fraction .", "label": "", "metadata": {}, "score": "66.94514"}
{"text": "PubMed View Article .Floyd NS , Woo SY , Teh BS , Prado C , Mai WY , Trask T , et al .: Hypofractionated intensity - modulated radiotherapy for primary glioblastoma multiforme .", "label": "", "metadata": {}, "score": "66.98202"}
{"text": "J Natl Cancer Inst 1993 , 85 ( 9 ) : 704 - 710 .PubMed View Article .Hulshof MC , Schimmel EC , Andries Bosch D , Gonzalez Gonzalez D : Hypofractionation in glioblastoma multiforme .", "label": "", "metadata": {}, "score": "66.99509"}
{"text": "Hypofractionated external beam radiotherapy has been used clinically for a number of years , particularly in the UK [ 2 - 4 ] .Given that quality of life has become one of the most significant issues in treatment decisions in prostate cancer , hypofractionation offers a shorter treatment course and increases convenience for prostate cancer patients .", "label": "", "metadata": {}, "score": "67.156586"}
{"text": "\" No fewer side effects for prostate proton therapy . \"Reuters News Service 12.27.12 . 2 Zietman A. Proton Beam and prostate cancer : An evolving debate .", "label": "", "metadata": {}, "score": "67.2285"}
{"text": "Finally , some consideration about the application of the linear - quadratic ( LQ ) model are needed .In fact , in radiotherapeutic applications , the LQ formalism is the tool most commonly used for quantitative predictions of dose / fractionations dependencies .", "label": "", "metadata": {}, "score": "67.29001"}
{"text": "A dose escalation protocol was implemented .This mandated treating at least 3 patients using dose level I which was defined as 54.4 Gy in 20 fractions over 4 weeks .", "label": "", "metadata": {}, "score": "67.30101"}
{"text": "NTT was determined as \" healthy tissue volume - tumor volume \" , i.e .For each patient , the planning volumes were well within the planning CT scans , so that the irradiated normal tissues were included in the CT volumes .", "label": "", "metadata": {}, "score": "67.36656"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .D'Souza , W.D. ; Rosen , II .Nontumor integral dose variation in conventional radiotherapy treatment planning .", "label": "", "metadata": {}, "score": "67.37085"}
{"text": "Our results indicate that although NTID was greater in SBRT than in 3D - CRT , secondary cancer risk associated to SBRT patients is significantly smaller than that calculated for 3D - CRT .", "label": "", "metadata": {}, "score": "67.38777"}
{"text": "Each treatment session may last from 30 and 60 minutes ; larger tumors take longer to treat than smaller ones .Why Use Cyberknife for Prostate Cancer ?", "label": "", "metadata": {}, "score": "67.39388"}
{"text": "PubMed View Article .Brandsma D , Stalpers L , Taal W , Sminia P , van den Bent MJ : Clinical features , mechanisms , and management of pseudoprogression in malignant gliomas .", "label": "", "metadata": {}, "score": "67.463165"}
{"text": "Although it is generally accepted that normal tissue complication risk and secondary malignancies risk increase as the ID increases , ID is rarely used in clinical practice to compare competing plans or to evaluate treatment outcome .", "label": "", "metadata": {}, "score": "67.58478"}
{"text": "Report 12 , Part I. Cancer : 1950 - 1990 .Radiat .Res .[ Google Scholar ] [ CrossRef ] .Schneider , U. Modelling the risk of secondary malignancies after radiotherapy .", "label": "", "metadata": {}, "score": "67.58644"}
{"text": "He added that if Yu is \" willing to make recommendations or clinical judgment based on this sort of data , I think he is at risk to doing a disservice to his patients . \" In the meantime , see the peer reviewed publication in the following link which provides more complete and accurate information : Click Here .", "label": "", "metadata": {}, "score": "67.703804"}
{"text": "The trial compared 76 Gy in conventional 2.0 Gy fractions ( Conventional IMRT ) to 70.2 Gy in 2.7 Gy fractions ( Hypofractionated IMRT ) , which was estimated to be equivalent to 84.4 Gy in 2.0 Gy fractions .", "label": "", "metadata": {}, "score": "67.728424"}
{"text": "More specifically , Lukka et al .[ 25 ] reported on the results of PR 05 , a Canadian randomized trial of 936 patients treated with either 66 Gy in 2 Gy fractions ( long arm ) or 52.5 Gy in 2.625-Gy fractions ( short arm ) .", "label": "", "metadata": {}, "score": "67.7847"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Tsuji , T. Yanagi , H. Ishikawa et al . , \" Hypofractionated radiotherapy with carbon ion beams for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "67.95238"}
{"text": "Urethra contouring encountered the intraprostatic urethra marked by the insertion of a three - way Foley catheter and extended by 5 mm caudally to include the apical urethra membrane .", "label": "", "metadata": {}, "score": "67.99182"}
{"text": "To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer .Methods .Between March 2004 and January 2008 , a total of 351 consecutive patients with clinically localised prostate cancer were treated with transrectal ultrasound guided high dose rate brachytherapy .", "label": "", "metadata": {}, "score": "68.00309"}
{"text": "Except for patient 6 , EARs for SBRT are systematically lower than EARs obtained for 3D - CRT .As a general rule , non tumor integral dose depends on a number of factors .", "label": "", "metadata": {}, "score": "68.1334"}
{"text": "Rogers et al .[ 8 ] reported a BC rate of 94 % at five years in 284 intermediate - risk patients treated with two implants at three fractions of 6.5 Gy .", "label": "", "metadata": {}, "score": "68.193344"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Hunt , M.A. ; Desobry , G.E. ; Fowble , B. ; Coia , L.R. Effects of low - density lateral interfaces on soft - tissue doses .", "label": "", "metadata": {}, "score": "68.20502"}
{"text": "69 , no .4 , pp .1084 - 1089 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Dearnaley , I. Syndikus , G. Sumo et al . , \" Conventional versus hypofractionated high - dose intensity - modulated radiotherapy for prostate cancer : preliminary safety results from the CHHiP randomised controlled trial , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "68.21902"}
{"text": "The latter study by Sultamen et al .[ 3 ] prescribed 60 Gy in 20 fractions to the GTV and 40 Gy in 20 fractions to the PTV in their study .", "label": "", "metadata": {}, "score": "68.23451"}
{"text": "However , it was discontinued after enrollment for patients with intermediate risk and continued for 2 years for those with high - risk .The clinical target volume ( CTV ) for intermediate - risk patients included the prostate and proximal seminal vesicles ( approximately 9 mm ) .", "label": "", "metadata": {}, "score": "68.23575"}
{"text": "Using the anatomy - based optimisation tool of SWIFT the dwell times were automatically adjusted ensuring the resulted 3D dose distribution fulfilled our PTV coverage requirements in compliance with OAR dose constraints ( Figure 1 b ) .", "label": "", "metadata": {}, "score": "68.27077"}
{"text": "Abbreviations : RPA : recursive partitioning analysis ; KPS : Karnofsky perfomans status ; TMZ : Temozolamide .Treatment goals and treatment delivery .All of the patients completed RT with concurrent TMZ with no treatment delay or interruption .", "label": "", "metadata": {}, "score": "68.34769"}
{"text": "Pseudoprogression was defined as clinical or radiological suggestion of tumor progression within three months of radiation completion followed by spontaneous recovery of the patient [ 7 ] .", "label": "", "metadata": {}, "score": "68.47154"}
{"text": "Follow - up and statistical analysis .Initial follow - up was performed at six weeks after the last BRT fraction and then every three months for the first year , every six months for the second year and annually thereafter .", "label": "", "metadata": {}, "score": "68.484245"}
{"text": "Factors associated with increased GU toxicity included pretreatment AUA symptoms score .Length of ADT did not influence GU toxicity .An Australian trial reported by Yeoh et al .", "label": "", "metadata": {}, "score": "68.50508"}
{"text": "Patient Selection and Treatment Planning .Eight patients with intrathoracic lesions were planned and treated with SBRT with a single - dose of 23 Gy .", "label": "", "metadata": {}, "score": "68.520065"}
{"text": "Patients .Adult patients with a histologically confirmed diagnosis of GBM were enrolled between 2005 and 2007 .Ethics approval was obtained from Alberta Cancer Ethics Review Board and all patients signed a study - specific consent form .", "label": "", "metadata": {}, "score": "68.65834"}
{"text": "[ Google Scholar ] .Hermanto , U. ; Frija , E.K. ; Lii , M.J. ; Chang , E.L. ; Mahajan , A. ; Woo , S.Y. Intensity - modulated radiotherapy ( IMRT ) and conventional three - dimensional conformal radiotherapy for high - grade gliomas : Does IMRT increase the integral dose to normal brain ?", "label": "", "metadata": {}, "score": "68.73506"}
{"text": "Careful progression through higher dose levels , in the setting of a clinical trial seems possible .Declarations .Acknowledgments .We thank the members of Radiation Oncology Clinical Research Unit for their support of this trial .", "label": "", "metadata": {}, "score": "68.893486"}
{"text": "There was 1 % grade 3 acute urinary toxicity , but no grade 3 acute rectal toxicity .At 5 years , the combined grade 2 to 4 late rectal toxicity was 4.5 % .", "label": "", "metadata": {}, "score": "68.89623"}
{"text": "On multivariate analysis , we found that the administration of 3 or more cycles of adjuvant TMZ was associated with better OS and PFS .Our current guidelines suggest 6 cycles of adjuvant TMZ as per EORTC / NCIC trial [ 1 ] .", "label": "", "metadata": {}, "score": "69.06683"}
{"text": "Research will continue and investigations of radiation fractionation , radiosensitizers therapy .Advances in radiation 3-Dimensional treatment planning and delivery - paranasal sinus .", "label": "", "metadata": {}, "score": "69.07182"}
{"text": "Dosimetry assessment parameters and OAR constraints are shown in Table 2 .Table 2 .Dosimetry parameters of the brachytherapy protocol with total physical prescription dose ( Gy ) and normal tissue dose constraints ( as percentages of the prescribed reference dose ) .", "label": "", "metadata": {}, "score": "69.115585"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. M. Duchess and L. J. Peters , \" What is the \u03b1 / \u03b2 ratio for prostate cancer ?", "label": "", "metadata": {}, "score": "69.14914"}
{"text": "Eighty percent of the patients potent at baseline remained potent at the time of recent analysis .McBride et al .[58 ] reported a Phase I multi - institutional trial of SBRT , also using the CyberKnife delivery platform .", "label": "", "metadata": {}, "score": "69.1824"}
{"text": "371 - 378 , 1987 .View at Google Scholar \u00b7 View at Scopus .G. Bolzicco , M. S. Favretto , E. Scremin , C. Tambone , A. Tasca , and R. Guglielmi , \" Image - guided stereotactic body radiation therapy for clinically localized prostate cancer : preliminary clinical results , \" Technology in Cancer Research and Treatment , vol .", "label": "", "metadata": {}, "score": "69.231155"}
{"text": "There was hence no statistically significant difference .Again , there was no statistically significant difference .The multivariate Cox regression analyses could not identify independent prognostic factors for biochemical failure .", "label": "", "metadata": {}, "score": "69.314255"}
{"text": "First , the datasets used in the modeling exercise were immature ( potentially resulting in an overestimate of treatment efficacy that was influencing the results of the analysis ) .", "label": "", "metadata": {}, "score": "69.32021"}
{"text": "PubMed View Article .Grills IS , Martinez AA , Hollander M : High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds .", "label": "", "metadata": {}, "score": "69.40282"}
{"text": "Example ( Carcinoma , extracapsular extension of tumor ) .COMPLICATION OF RADIOTHERAPY Acute reactions - During the course of radiotherapy due to tissue toxicity and resolve over several weeks .", "label": "", "metadata": {}, "score": "69.426094"}
{"text": "Published clinical data will be classified into four categories .The first category includes retrospective clinical trials that have been analyzed post hoc to evaluate .", "label": "", "metadata": {}, "score": "69.49438"}
{"text": "Secondary endpoints included PFS , pattern of failure , OS and incidence of pseudoprogression .PFS was defined from the day of surgery till the documentation of disease progression clinically and/ or radiologically .", "label": "", "metadata": {}, "score": "69.51134"}
{"text": "You might wonder how the robot knows where the tumor is located .Between 1 and 10 days before treatment with Cyberknife , a patient with prostate cancer will see an urologist to have gold markers , known as \" fiducials \" , placed in the prostate as a way of marking the target .", "label": "", "metadata": {}, "score": "69.6635"}
{"text": "INTRA CAVITARY / INTRA LUMINAL Radioactive source placed in natural body cavities .PRE AND POSTOPERATIVE THERAPY Preoperative radiation are used for destruction of peripheral tumor cells , the potential control of sub - clinical disease .", "label": "", "metadata": {}, "score": "69.69867"}
{"text": "J. D. Cox , D. J. Grignon , R. S. Kaplan , J. T. Parsons , and P. F. Schellhammer , \" Consensus statement : guidelines for PSA following radiation therapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "69.8496"}
{"text": "ratio , defined as the dose at which killing of cell by linear ( . and quadratic ( .components are equal , is used to quantify the fractionation sensitivity of tissues and tumors .", "label": "", "metadata": {}, "score": "69.96129"}
{"text": "The authors would like to thank Uwe Schneider for his helpful suggestions .His valuable comments helped to significantly improve the manuscript .References .Van Leeuwen , F.E. ; Travis , L.B. Second Cancers .", "label": "", "metadata": {}, "score": "70.05873"}
{"text": "Acute grade 2 GU symptoms occurred in 20 - 30 % of patients .Actuarial rectal bleeding at 2 years did not differ significantly between fractional dose levels .", "label": "", "metadata": {}, "score": "70.1119"}
{"text": "The standard radiation dose is 60 Gy in 1.8 - 2.0 Gy per fraction given over 6 weeks .Most dose escalation studies were done before the era of intensity modulated radiation therapy ( IMRT ) .", "label": "", "metadata": {}, "score": "70.11374"}
{"text": "[ Google Scholar ] [ CrossRef ] .Followill , D. ; Geis , P. ; Boyer , A. Estimates of whole - body dose equivalent produced by beam intensity modulated conformal therapy .", "label": "", "metadata": {}, "score": "70.13225"}
{"text": "One way of concentrating the radiation dose in the tumor tissue and the limiting the dose to the surrounding normal tissues .Branchy therapy is used as a boosted dose of radiation to specific site or for treatment for recurrence .", "label": "", "metadata": {}, "score": "70.14722"}
{"text": "11 - 18 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Hypofractionated External - Beam Radiotherapy for Prostate Cancer .", "label": "", "metadata": {}, "score": "70.16423"}
{"text": "Linear Quadratic Model and BED Formalism .In the classic Linear Quadratic ( LQ ) model , the cell fraction surviving an irradiation ( SF ) is described by the following function : .", "label": "", "metadata": {}, "score": "70.40224"}
{"text": "The tumor position will be tracked during the Cyberknife treatment using the fiducials .A week or so after fiducial placement , a CT simulation is performed .", "label": "", "metadata": {}, "score": "70.41177"}
{"text": "Therefore , the objective of the present study was to contribute to available experience by reporting our mature results of HDR BRT in 351 consecutive patients treated with a hypofractionated two - implant treatment regime .", "label": "", "metadata": {}, "score": "70.501564"}
{"text": "Soete et al .[ 23 ] used even higher dose per fraction , 3.5 Gy , to treat 36 patients in a phase II trial .", "label": "", "metadata": {}, "score": "70.50974"}
{"text": "\" The visual comparison below even further demonstrates the significant advantages of the use of proton therapy to deliver less radiation to normal healthy tissue .", "label": "", "metadata": {}, "score": "70.53651"}
{"text": "Purpose .To determine the safety and efficacy of hypofractionated intensity modulated radiation therapy ( Hypo - IMRT ) using helical tomotherapy ( HT ) with concurrent low dose temozolomide ( TMZ ) followed by adjuvant TMZ in patients with glioblastoma multiforme ( GBM ) .", "label": "", "metadata": {}, "score": "70.54878"}
{"text": "This is imputable to the fact that in the case of SBRT the dose - response curve for carcinoma induction is highly non - linear .", "label": "", "metadata": {}, "score": "70.61428"}
{"text": "The scientific rationale for such \" hypofractionated \" treatment lies in the unique radiobiologic properties of prostate cancer .Radiobiologic Rationale .The radiobiological basis of hypofractionation for prostate cancer assumes that the prostate cancer cells respond to radiotherapy in a manner that can be mathematically modeled with a classic linear - quadratic equation : . , represent linear and quadratic components of the equation [ 6 ] .", "label": "", "metadata": {}, "score": "70.61813"}
{"text": "Grade 3 - 4 hematological toxicity was limited to two patients and one patient developed Grade 4 Pneumocystis jiroveci pneumonia .Conclusion .Hypo - IMRT using HT given with concurrent TMZ is feasible and safe .", "label": "", "metadata": {}, "score": "70.84094"}
{"text": "The treatment goals are as described in Table 2 .The dose - volume analysis for the PTV and OARs is showed in Table 3 .", "label": "", "metadata": {}, "score": "70.8842"}
{"text": "After an initial dose - finding period , patients received daily fractions of 3.3 Gy equivalent , 4 days per week to a total dose of 66 Gy equivalent .", "label": "", "metadata": {}, "score": "70.886856"}
{"text": "5 , pp .1932 - 1936 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Introduction to Cyberknife for Prostate Cancer .", "label": "", "metadata": {}, "score": "71.04268"}
{"text": "The coverage change decisions for proton therapy for prostate cancer patients will impact many individual prostate cancer patients but will not have a significant impact on total reimbursement for proton therapy centers .", "label": "", "metadata": {}, "score": "71.077866"}
{"text": "Biochemical failure was defined according to the Phoenix Consensus and toxicity evaluated using the Common Toxicity Criteria for Adverse Events version 3 .Results .The median follow - up time was 59.3 months .", "label": "", "metadata": {}, "score": "71.09727"}
{"text": "Organ Equivalent Dose .PTV .Planning Target Volume .RED .Risk Equivalent Dose .SBRT .Stereotactic Body Radiation Therapy .TPS .Treatment Planning System .", "label": "", "metadata": {}, "score": "71.29657"}
{"text": "To eradicate well oxygenated tumor cells at the periphery .PRINCIPAL OF RADIATION To deliver a precise dose of radiation to a definite tumor volume with minimal damage .", "label": "", "metadata": {}, "score": "71.506325"}
{"text": "The site - specific parameter \u03b2 is taken from [ 30 ] and listed in Table 1 for each organ of interest in the present study .", "label": "", "metadata": {}, "score": "71.55299"}
{"text": "All GU and the majority of GI symptoms had resolved 2 months after treatment .Although no grade 3 - 4 side effects were observed , the investigators noted an increase of grade 1 - 2 early side effects as compared to a conventional regimen .", "label": "", "metadata": {}, "score": "71.66551"}
{"text": "Even though direct comparisons are difficult , our results are consistent with the experiences of other groups using a similar two - implant approach .Mark et al .", "label": "", "metadata": {}, "score": "71.692604"}
{"text": "Ritter et al .[ 24 ] reported a preliminary analysis of toxicity with hypofractionated radiotherapy at the 2006 ASTRO meeting .This collaborative effort reported on 110 patients treated with image - guided IMRT to a total dose of 64.68 Gy in 2.94 Gy fractions given 4 to 5 days per week .", "label": "", "metadata": {}, "score": "71.73638"}
{"text": "Lancet 2005 , 366 , 2087 - 2106 .[ Google Scholar ] .Brenner , D.J. ; Curtis , R.E. ; Hall , E.J. ; Ron , E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery .", "label": "", "metadata": {}, "score": "71.78148"}
{"text": "Almost half of the patients ( 52 % ) were RPA class IV and the remaining was either class III ( 16 % ) or V ( 32 % ) .", "label": "", "metadata": {}, "score": "71.90872"}
{"text": "Chemotherapy .Patients were given TMZ at dose of 75 mg / m2/ day concomitant with RT , beginning the day of the first fraction of radiation , including weekends and holidays and ending on the day of the last radiation fraction .", "label": "", "metadata": {}, "score": "72.03559"}
{"text": "[ Google Scholar ] [ CrossRef ] .Greco , C. ; Wolden , S. Current status of radiotherapy with proton and light ion beams .", "label": "", "metadata": {}, "score": "72.11014"}
{"text": "The efficacy and safety of this regimen were demonstrated by this phase I study .Our data are consistent with the results reported by Stupp et al .", "label": "", "metadata": {}, "score": "72.32703"}
{"text": "To our knowledge , there are no studies investigating ID in stereotactic body radiation therapy and comparing SBRT with \" traditional \" techniques .Generally , SBRT does not lead to unacceptable side effects if the serial organs are excluded from high dose regions and the organs at risk constraints are respected .", "label": "", "metadata": {}, "score": "72.52178"}
{"text": "The primary endpoints were feasibility and safety of Hypo - IMRT with concurrent TMZ .Secondary endpoints included progression free survival ( PFS ) , pattern of failure , overall survival ( OS ) and incidence of pseudoprogression .", "label": "", "metadata": {}, "score": "72.711655"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. G. Dale and B. Jones , \" Is the \u03b1 / \u03b2 for prostate tumors really low ?", "label": "", "metadata": {}, "score": "72.73599"}
{"text": "There are of course some limitations in our study .It encompassed 351 patients who were not treated within a multi - institutional framework but at a single tertiary - care center .", "label": "", "metadata": {}, "score": "72.75149"}
{"text": "The 5-year , biochemical progression free survival ( bPFS ) for level 1 was 94.7 % , with no difference between fractionation dose schedules ( .", "label": "", "metadata": {}, "score": "72.773544"}
{"text": "Results .Patient characteristics .Between April 2005 and July 2007 , 25 patients with histologically proven GBM were prospectively treated with Hypo - IMRT using HT , with concurrent low dose TMZ chemotherapy followed by adjuvant TMZ according to the above - described protocol .", "label": "", "metadata": {}, "score": "72.77428"}
{"text": "The study included 16 patients and examined four dose levels .A total dose of 60 Gy in 3 Gy / fraction , 4 Gy / fraction , 5 Gy / fraction , and 6 Gy / fraction , was prescribed in dose levels 1 , 2 , 3 and 4 , respectively .", "label": "", "metadata": {}, "score": "72.86441"}
{"text": "[ Google Scholar ] [ CrossRef ] .Engels , H. ; Wambersie , A. Relative biological effectiveness of neutrons for cancer induction and other late effects : A review of radiobiological data .", "label": "", "metadata": {}, "score": "72.907364"}
{"text": "The physician uses this scan to delineate the area to be treated as well as those organs to avoid .This information is used to create the treatment plan .", "label": "", "metadata": {}, "score": "72.99126"}
{"text": "3D - CRT ) .In these studies ID was calculated by DVHs or by the product of mean dose and irradiated volume [ 12 , 13 , 14 , 15 , 16 ] .", "label": "", "metadata": {}, "score": "73.06566"}
{"text": "Blood chemistry was obtained at the 3- and 6-months visits and as needed thereafter .The common terminology criteria for adverse events ( CTC - AE ) were used for grading acute and late side effects .", "label": "", "metadata": {}, "score": "73.09851"}
{"text": "However , none was identified in our cohort of patients .We investigated the potential association between several prognostic factors and increased risk of GBM progression .", "label": "", "metadata": {}, "score": "73.11905"}
{"text": "Our data are consistent with results reported EORTC / NCIC trial , with a median OS of 15.67 months a median PFS of 6.7 months .", "label": "", "metadata": {}, "score": "73.247284"}
{"text": "Dose specification was given as the mean dose on the PTV surface .The prescribed reference dose was 9.5 Gy delivered four times to a total dose of 38.0 Gy using two implants .", "label": "", "metadata": {}, "score": "73.26219"}
{"text": "Abbreviations : PFS : progression free survival ; HR : hazard ration ; CI : confidence interval ; KPS : Karnofsky performance status ; RPA : recursive partitioning analysis ; TMZ : Temozolomide ; GTR : gross total resection ; STR : subtotal resection ; RT : radiation therapy .", "label": "", "metadata": {}, "score": "73.34109"}
{"text": "Low - risk patients had clinical stage of T1 or T2 , PSA less than or equal to 10 , and Gleason score less than 7 .", "label": "", "metadata": {}, "score": "73.435165"}
{"text": "Non - Tumour Integral Dose ( Gy \u00d7 liter ) and increase percentage of SBRT respect to 3D - CRT .Table 3 .Non - Tumour Integral Dose ( Gy \u00d7 liter ) and increase percentage of SBRT respect to 3D - CRT .", "label": "", "metadata": {}, "score": "73.4472"}
{"text": "In this context , new high - precision technologies like intensity modulated radiotherapy ( IMRT ) and SBRT represent major advances in cancer treatment .The high degree of conformity associated with these techniques is often obtained by increasing the number of fields and using fixed - shape or dynamic conformal arc beams .", "label": "", "metadata": {}, "score": "73.52015"}
{"text": "BED has the dimensions of dose , and represents a quantity by which different fractionation regimens can be compared .In fact , two fractionation schedules are taken as \" equivalent \" if they give the same radiobiological effect .", "label": "", "metadata": {}, "score": "73.52864"}
{"text": "The remainder of the patients tolerated the treatment with mild or no acute toxicity .Prognostic factors and outcome .At a median follow - up of 12.4 months , the median OS was 15.67 months ( 95 % CI 11.56 - 20.04 ) and the median PFS was 6.7 months ( 95 % CI 4.0 - 14.0 ) ( Figure 1 ) .", "label": "", "metadata": {}, "score": "73.598526"}
{"text": "MUCOSITIS LIP LUBRICANTS Topical anesthetics - Xylocaine HCl .Analgesic agents .XEROSTOMIA Acinar cell atrophy , hypo - vascularity , altered neurologic function , decrease buffering capacity , altered oral microbial flora treatment .", "label": "", "metadata": {}, "score": "73.94853"}
{"text": "MUCOSITIS Epithelial thinning , altered vascular supply , fibrosis in connective tissue , friable mucosa and hyalinization of collagen ( 1 to 2 weeks ) .", "label": "", "metadata": {}, "score": "73.95444"}
{"text": "In one case a treatment with eight non - coplanar fixed fields was planned .For all plans , prescription was 90 % of the total dose ( 23 Gy ) .", "label": "", "metadata": {}, "score": "73.996445"}
{"text": ", IJROBP 2003;55:194 - 203 , \" International Journal of Radiation Oncology Biology Physics , vol .57 , no . 2 , pp .593 - 595 , 2003 .", "label": "", "metadata": {}, "score": "74.13539"}
{"text": "[ Google Scholar ] .Hall , E.J. Review of Essential and Topical Radiobiology .In Radiobiological Modelling in Radiation Oncology ; Dale , R. , Jones , B. , Eds . ;", "label": "", "metadata": {}, "score": "74.16545"}
{"text": "Results were also reported according to prognostic groups .For low , intermediate and high - risk disease , the 5-year bRFS rates using ASTRO consensus definition were 97 % , 88 % , and 70 % .", "label": "", "metadata": {}, "score": "74.236176"}
{"text": "5 , pp .1254 - 1259 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. D. Cox , D. J. Grignon , R. S. Kaplan , J. T. Parsons , and P. F. Schellhammer , \" Consensus statement : guidelines for PSA following radiation therapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "74.25884"}
{"text": "Three patients were treated with dose level I ( 54.4 Gy in 20 fractions over 4 weeks ) and none of them developed any of the defined dose - limiting toxicity .", "label": "", "metadata": {}, "score": "74.314964"}
{"text": "At a median follow up of 66 months , there were no significant differences in the A - bRFS or N - bRFS rates ( 85 % vs. 88 % ) .", "label": "", "metadata": {}, "score": "74.35828"}
{"text": "Int J Radiat Oncol Biol Phys 2009 , 73 ( 2 ) : 473 - 478 .PubMed View Article .Fenwick JD , Tome WA , Soisson ET , Mehta MP , Rock MT : Tomotherapy and other innovative IMRT delivery systems .", "label": "", "metadata": {}, "score": "74.37905"}
{"text": "Phys .[ Google Scholar ] .Mock , U. ; Georg , D. ; Bogner , J. ; Auberger , T. ; P\u00f6tter , R. Treatment planning comparison of conventional , 3D conformal , and intensity - modulated photon ( IMRT ) and proton therapy for paranasal sinus carcinoma .", "label": "", "metadata": {}, "score": "74.47688"}
{"text": "The toxicity consisted of incontinence , urgency , and frequency .Most were not repeated when patients were followed in time .Factors associated with increased GU toxicity included pre - treatment AUA symptoms score .", "label": "", "metadata": {}, "score": "74.71925"}
{"text": "King et al .[ 56 , 57 ] reported a follow - up of a phase II trial .The treatment consisted of SBRT with a total dose of 36.25 Gy in 5 fractions using the Cyberknife treatment platform .", "label": "", "metadata": {}, "score": "74.750244"}
{"text": "Treatment toxicity .Concurrent RT and TMZ related acute side effects are reported in Table 4 .One patient developed Pneumocystis jiroveci pneumonia infection requiring admission to the intensive care unit ( ICU ) for ventilatory support .", "label": "", "metadata": {}, "score": "75.042725"}
{"text": "The clinical target volume ( CTV ) included the GTV with a non - uniform 1 cm margin , excluding areas extending beyond the dura , calvarium or other anatomical boundaries .", "label": "", "metadata": {}, "score": "75.13818"}
{"text": "Using Nadir + 2 definition for BF , there rates of BF were 15 % for CIMRT vs 19 % HIMRT .Rates for LRF / DM were 1.0 % and 1.3 % for CIMRT and HIMRT at 5 years .", "label": "", "metadata": {}, "score": "75.145996"}
{"text": "4 , pp . 1033 - 1039 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Barnes , H. Pass , and A. DeLuca , \" Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy ( IORT ) , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "75.15261"}
{"text": "Clinical features - discomfort , bad taste , parasthesia , fistula , infection and fracture .TREATMENT Hyper baric oxygen therapy , IV fluids , nutritional supplement , removing of underlying tropical antibiotic and antiseptic .", "label": "", "metadata": {}, "score": "75.28113"}
{"text": "Furthermore , they also reported an equivalent overall survival rate of 85 % in both hypofractionated and conventional regimen .Furthermore , another prospective phase III randomized clinical trial by Arcangeli et al .", "label": "", "metadata": {}, "score": "75.313995"}
{"text": "In this form the function \u03bc ( agex , agea ) depends on the age at exposure ( agex ) , the attained age ( agea ) and two organ - dependent parameters \u03b3 e and \u03b3 a , taken from [ 30 ] and listed in Table 1 .", "label": "", "metadata": {}, "score": "75.604675"}
{"text": "This paper analyses in detail the clinical outcome of our two - implant approach during the four - year time frame of 2004 - 2008 when we treated consecutively a cohort of 351 patients .", "label": "", "metadata": {}, "score": "75.61565"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] .Nagata , Y. ; Takayama , K. ; Matsuo , Y. ; Norihisa , Y. ; Mizowaki , T. ; Sakamoto , T. ; Sakamoto , M. ; Mitsumori , M. ; Shibuya , K. ; Araki , N. ; et al .", "label": "", "metadata": {}, "score": "75.686264"}
{"text": "Cumulative incidence was 4.1 % in CIMRT and 5.9 % in HIMRT .There was a significant increase in Grade 2 + GU toxicity with hypofractionated arm in this update .", "label": "", "metadata": {}, "score": "75.71013"}
{"text": "The general properties of the model applied are discussed elsewhere [ 30 ] and will not be repeated here .However , in the following an overview of the formalism is provided .", "label": "", "metadata": {}, "score": "76.03024"}
{"text": "How Does Cyberknife Compare to Conventionally Fractionated External Beam Therapy ?So far , there is no study that has compared Cyberknife with standard external beam in a randomized fashion .", "label": "", "metadata": {}, "score": "76.207184"}
{"text": "Freedom from biochemical recurrence ( FFBR ) was calculated according to the American Society for Therapeutic Radiology and Oncology consensus definition [ 19 ] .Freedom from biochemical recurrence at 5 years was 82 % , 56 % , and 39 % for the low- , intermediate- , and high - risk groups , respectively .", "label": "", "metadata": {}, "score": "76.69913"}
{"text": "A comparison between SBRT and 3D - CRT treatment plans is reported in Table 2 .All plans were generated with commercially available treatment planning systems ( TPS ) .", "label": "", "metadata": {}, "score": "76.714096"}
{"text": "Blogs .Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer .Reporter :J Taylor Whaley The Abramson Cancer Center of the University of Pennsylvania Last Modified : October 3 , 2011 .", "label": "", "metadata": {}, "score": "76.74161"}
{"text": "No acute grade 3 or 4 toxicities were observed .The grade 2 GU acute toxicity was significantly lower in the hypofractionated arm : 19.1 % versus 47.7 % ( . )", "label": "", "metadata": {}, "score": "76.7745"}
{"text": "J. Radiat .Oncol .Biol .Phys .[ Google Scholar ] [ CrossRef ] .Lung Cancer STARS ( Stereotactic Radiotherapy vs. Surgery ) Trial , International Randomized Study to Compare CyberKnife Stereotactic Radiotherapy with Surgical Resection in Stage I Non - Small Cell Lung Cancer .", "label": "", "metadata": {}, "score": "76.99475"}
{"text": "The Fibonacci dose escalation protocol was implemented to establish a safe radiation fractionation regimen .The protocol defined radiation therapy ( RT ) dose level I as 54.4 Gy in 20 fractions over 4 weeks and dose level II as 60 Gy in 22 fractions over 4.5 weeks .", "label": "", "metadata": {}, "score": "77.10814"}
{"text": "Phys .[ Google Scholar ] [ CrossRef ] .Schneider , U. ; Sumila , M. ; Robotka , J. Site - specific dose - response relationship for cancer induction from the combined Japanese A - bomb and Hogkin cohorts for doses relevant to radiotherapy .", "label": "", "metadata": {}, "score": "77.28415"}
{"text": "Directly implanted source may be used to deliver the radiation by covering the unexposed areas with bandages , holders , wax and shields .MOLDS / PLAQUES Radioactive source is loaded into a surface mould and placed within the tumor .", "label": "", "metadata": {}, "score": "77.44159"}
{"text": "Acute toxicity was defined as symptoms that had completely resolved by six months after BRT .Adverse events that persisted or appeared beyond six months were considered late toxicity .", "label": "", "metadata": {}, "score": "77.55452"}
{"text": "No grade 3 or higher toxicities were observed .The authors concluded that the regimen was effective and safe .Furthermore , Soete et al .", "label": "", "metadata": {}, "score": "77.638756"}
{"text": "However , the authors relied again on a short - term endpoint ( biochemical control at 3 years ) .From the original population of 192 patients , the authors managed to analyze the results in 121 men .", "label": "", "metadata": {}, "score": "77.71149"}
{"text": "[ 3 ] reported on a group of 197 patients with a four - year BC rate of 87 % in 86 high risk - cases .", "label": "", "metadata": {}, "score": "77.83111"}
{"text": "TREATMENT Speech therapy and prosthesis .Due to fibrosis stress of muscles .TREATMENT Physiotherapy , excises , muscle relaxants and analgesics injection .DENTOFACIAL ABNORMALITIES / PAIN Affects the facial skeleton , growth and development agenesis of teeth , abnormal micrognathia .", "label": "", "metadata": {}, "score": "77.86698"}
{"text": "Acute GI grade 1 and grade 2 toxicities were 30 % and 14 % , respectively .The three - year actuarial biochemical control rate was 97 % .", "label": "", "metadata": {}, "score": "77.873"}
{"text": "There was no acute RTOG grade 3 or 4 toxicity .At 2 years , there were 4 % grade 2 GI and 4.25 % grade 2 GU toxicity .", "label": "", "metadata": {}, "score": "77.929184"}
{"text": "Caution is advised in the presence of bio - mathematical model which use radiobiological parameters .In fact , although mathematical models are widely used to compare different radiotherapy technique and different fractionation scheme , the radiobiological parameters on which they are funded are still not completely optimized , thus unavoidably introducing some degree of approximation .", "label": "", "metadata": {}, "score": "77.95612"}
{"text": "The GI toxicity was lower in both hypofractionated treatment arms : 3.6 % in the 60 Gy group and the 1.4 % in the 57 Gy group .", "label": "", "metadata": {}, "score": "77.98042"}
{"text": "Patients enrolled in the clinical trial over a period of 1964 to 1984 .The trial included men with early ( T1-T2 ) and advanced ( T3-T4 ) disease that were treated by external beam radiotherapy .", "label": "", "metadata": {}, "score": "78.07144"}
{"text": "J. Cancer 1998 , 34 , 2068 - 2075 .[ Google Scholar ] [ CrossRef ] .Int .J. Radiat .Oncol .Biol .", "label": "", "metadata": {}, "score": "78.09364"}
{"text": "The rate of biochemical control was 97 % at 14 months by the Phoenix definition and 76 % at 3 years by the older ASTRO consensus definition .", "label": "", "metadata": {}, "score": "78.10988"}
{"text": ", IJROBP 2001;50:1021 - 1031 , \" International Journal of Radiation Oncology Biology Physics , vol .52 , no .5 , pp .1427 - 1428 , 2002 .", "label": "", "metadata": {}, "score": "78.24832"}
{"text": "At a median follow - up of 40 months ( range , 9 - 58 months ) , 10 patients died of other causes and 9 were lost to follow - up .", "label": "", "metadata": {}, "score": "78.275185"}
{"text": "The acute rectal toxicity scores were 0 in 20 , 1 in 61 , and 2 in 19 patients .A great majority of patients experienced grade 0 - 1 acute gastrointestinal ( GI)/genitourinary ( GU ) toxicities .", "label": "", "metadata": {}, "score": "78.30412"}
{"text": "Nonetheless , the clinical research for proton therapy continues to develop and grow and will in time differentiate from IMRT and prove it is a more effective therapy .", "label": "", "metadata": {}, "score": "78.30446"}
{"text": "Epithelial malignancy 1.8 to 2 Gy per fraction for 5 weeks ( 6000 to 6500cGy ) .Lymphomas 180 to 200cGy per day ( 3500 to 5000cGy ) .", "label": "", "metadata": {}, "score": "78.47517"}
{"text": "Final follow - up questionnaires were returned by 344 ( 98 % ) patients during November and December 2010 .Seven ( 2 % ) patients were not alive at the time of reporting .", "label": "", "metadata": {}, "score": "78.51771"}
{"text": "Results .Clinical outcome .Of the 351 patients , 21 ( 5.9 % ) developed biochemical relapses with five ( 1.4 % ) developing distant metastatic disease .", "label": "", "metadata": {}, "score": "78.535164"}
{"text": "The AUA GU symptom score increases returned to baseline in the 45-Gy and 50-Gy group but persisted in the 47.5-Gy dose level patients .", "label": "", "metadata": {}, "score": "78.707695"}
{"text": "SHIM , AUA , and EPIC scores were used to assess quality of life in 56 % of the patients who filled out the questionnaires .", "label": "", "metadata": {}, "score": "78.739136"}
{"text": "PubMed View Article .Thomas SD , Mackenzie M , Field GC , Syme AM , Fallone BG : Patient specific treatment verifications for helical tomotherapy treatment plans .", "label": "", "metadata": {}, "score": "78.80137"}
{"text": "A recent work by Petti et al .[ 33 ] showed that peripheral dose in CyberKnife radiosurgery is due largely to leakage radiation .They measured the radiation dose at different distances outside the treatment field finding that for distances larger than 40 cm from the field edge radiation leakage is the dominant component and is directly related to the number of MU delivered .", "label": "", "metadata": {}, "score": "78.81976"}
{"text": "In patients with clinically localised prostate cancer , high dose rate ( HDR ) brachytherapy ( BRT ) has emerged as a safe and effective monotherapeutic modality [ 1 - 8 ] .", "label": "", "metadata": {}, "score": "78.992744"}
{"text": "Hormonal therapy was prescribed neoadjuvantly and continued concurrently with radiation and adjuvantly for an overall duration of median nine months ( range , 3 - 14 months ) .", "label": "", "metadata": {}, "score": "79.17327"}
{"text": "Based on the observed difference between the 2 groups , the investigators derived an estimate of 1.2 Gy ( 95 % confidence interval , 0.03 - 4.1 ) for .", "label": "", "metadata": {}, "score": "79.18404"}
{"text": "All patients completed concurrent RT and TMZ , and 19 patients ( 76.0 % ) received adjuvant TMZ .The median OS was 15.67 months ( 95 % CI 11.56 - 20.04 ) and the median PFS was 6.7 months ( 95 % CI 4.0 - 14.0 ) .", "label": "", "metadata": {}, "score": "79.22844"}
{"text": "All the structures were contoured in such a way as not to overlap with adjacent structures ( i.e . , every voxel was assigned to only one structure ) .", "label": "", "metadata": {}, "score": "79.232056"}
{"text": "The jaw width , pitch , and modulation factor used for our study were 2.5 , 0.430 , and 3 cm , respectively .The dose calculation grid resolution was 2 mm .", "label": "", "metadata": {}, "score": "79.239204"}
{"text": "Int J Radiat Oncol Biol Phys 2011 , 81 ( 4 ) : 1066 - 1074 .PubMed View Article .Mahindra AK , Grossman SA : Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors .", "label": "", "metadata": {}, "score": "79.24162"}
{"text": "Cyberknife , while precise , still does have the potential for side effects because surrounding tissues can still receive some radiation .The side effects include urinary irritation symptoms such as urgency , frequency , and burning with urination .", "label": "", "metadata": {}, "score": "79.33913"}
{"text": "The same structures were then used for 3D - CRT treatment planning ( TPS ) with Eclipse \u00ae software ( Eclipse 7.3.10 Varian , Palo Alto , CA , USA ) .", "label": "", "metadata": {}, "score": "79.342865"}
{"text": "Primary end - points were feasibility and late GI toxicity by RTOG scale , while secondary end - points included acute GI toxicity , acute and late genitourinary ( GU ) toxicity , biochemical control , and survival .", "label": "", "metadata": {}, "score": "79.37459"}
{"text": "Measurements have shown excellent agreement between dose delivered and that calculated by both TPSs , with absolute dose difference being consistently within 1.0 % for Eclipse and within 0.9 % for BrainLAB TPS .", "label": "", "metadata": {}, "score": "79.48568"}
{"text": "The use of helical tomotherapy ( HT ) can provide different geometric flexibility and modulation techniques over standard IMRT .Such superior control of dose distribution could allow for better dose uniformity within the target and/ or sparing of organs at risk [ 5 ] .", "label": "", "metadata": {}, "score": "79.55817"}
{"text": "Results .A total of 25 patients were prospectively enrolled with a median follow - up of 12.4 months .The median age at diagnosis was 53 years .", "label": "", "metadata": {}, "score": "79.807465"}
{"text": "Clinical Trials.gov Identifier : NCT00840749 .Aird , E.G.A. Second cancer risk , concomitant exposures and IRMER .Brit .J. Radiol .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "80.0455"}
{"text": "ranging from 1.2 to 4 have been reported , while most data support values at the lower end of this spectrum [ 6 - 13 ] .", "label": "", "metadata": {}, "score": "80.14386"}
{"text": "We believe these changes are short sighted and without merit and will provide the basis for our opinion below .The information used in the articles is flawed and incomplete . -", "label": "", "metadata": {}, "score": "80.30184"}
{"text": "Toxicity was scored per event with 4.8 % acute Grade 3 genitourinary and no acute Grade 3 gastrointestinal toxicity .Late Grade 3 genitourinary and gastrointestinal toxicity were respectively 3.4 % and 1.4 % .", "label": "", "metadata": {}, "score": "80.37942"}
{"text": "Radiation oncology is a medical specialty that utilizes ionizing radiation to treat many different types of malignancies .Oral cancer - 3.5 % of all malignancies .", "label": "", "metadata": {}, "score": "80.4836"}
{"text": "Fifty - one patients ( 51 % ) received androgen deprivation therapy for a period no longer than 6 months .The median followup was 66 months .", "label": "", "metadata": {}, "score": "80.64825"}
{"text": "PubMed View Article .Curran WJ Jr , Scott CB , Horton J , Nelson JS , Weinstein AS , Fischbach AJ , et al .", "label": "", "metadata": {}, "score": "80.725296"}
{"text": "Another series from the United Kingdom has been reported by Livsey et al .[ 18 ] at the Christie Hospital .The series included more than 700 men treated with hypofractionated radiotherapy over a period from 1995 to 1998 using 3.13 Gy fractions to 50 Gy .", "label": "", "metadata": {}, "score": "80.83547"}
{"text": "51 patients received concurrent hormonal therapy with a 6-month maximum duration .Median follow up was 66 months ( 3 - 75 months ) .", "label": "", "metadata": {}, "score": "81.08499"}
{"text": "The M.D. Anderson study is referenced in the following link : Click Here .In today 's world it is common knowledge that less radiation causes less harm .", "label": "", "metadata": {}, "score": "81.09824"}
{"text": "PubMed View Article .Panet - Raymond V , Souhami L , Roberge D , Kavan P , Shakibnia L , Muanza T , et al .", "label": "", "metadata": {}, "score": "81.232124"}
{"text": "The reported 94 % BC at 60 months is in accordance with mature HDR monotherapy data from other institutions , suggesting high PSA relapse - free survival rates for all risk groups .", "label": "", "metadata": {}, "score": "81.31975"}
{"text": "In the present study , given the same beam energy ( 6 MV ) , one would expect that the smaller margin used in SBRT ( 2 mm vs .", "label": "", "metadata": {}, "score": "81.62926"}
{"text": "Descriptive analysis was conducted for all study variables .Mean , standard deviation , median ( range ) were reported for continuous variables , frequency and percentages were reported for the categorical variables .", "label": "", "metadata": {}, "score": "81.66157"}
{"text": "The median overall survival was 14.4 months , and the median disease - free survival was 7.7 months , both of which were comparable to those reported by the EORTC / NCIC trial [ 1 ] .", "label": "", "metadata": {}, "score": "81.70433"}
{"text": "From March 2004 to January 2008 , 351 patients received two implants , separated by two weeks , each of two fractions of 9.5 Gy .", "label": "", "metadata": {}, "score": "81.81348"}
{"text": "In the high - risk patients , separate CTV and PTV were designed to treat the distal portions of the seminal vesicles , periprostatic , periseminal vesicle , external iliac , obturator , and internal iliac lymph nodes .", "label": "", "metadata": {}, "score": "81.923195"}
{"text": "Ann .ICRP 2007 , 37 , 1 - 332 .Health Risks from Exposure to Low Levels of Ionizing Radiation : BEIR VII , Phase 2 ; National Academy Press : Washington , DC , USA , 2006 .", "label": "", "metadata": {}, "score": "82.00442"}
{"text": "PubMed View Article .Brachytherapy 2008 , 7 : 7 - 11 .PubMed View Article .Copyright .\u00a9 Tselis et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "82.237976"}
{"text": "As a general rule , EARs for SBRT patients are smaller than secondary cancer risk for patients that received standard conformal radiation therapy .Exceptions are represented by patients 5 and 6 , where EARs for left lung ( patients 5 and 6 ) and esophagus ( patient 6 ) are higher for SBRT rather than 3D - CRT .", "label": "", "metadata": {}, "score": "82.3147"}
{"text": "Just like the maturation of IMRT , significant improvements in radiation dose delivery can be expected with IMPT thus further supporting its superiority to conventional radiation therapy .", "label": "", "metadata": {}, "score": "82.52567"}
{"text": "Another key characteristic of Cyberknife is the use of real - time IGRT .What this means is that the motion of the tumor is tracked and the radiation , because it is delivered via a robotic arm , can be directed based on the motion of the tumor .", "label": "", "metadata": {}, "score": "82.71956"}
{"text": "There is increased risk to healthy tissue receiving unnecessary radiation .- There is no denying the science when comparing proton therapy and conventional x - ray therapy .", "label": "", "metadata": {}, "score": "82.74904"}
{"text": "Who Is A Candidate for Treatment ?Cyberknife is used for patients with early stage , localized disease .Patients who are considered high risk for lymph node involvement or have documented lymph node involvement are not good candidates for Cyberknife .", "label": "", "metadata": {}, "score": "82.93681"}
{"text": "Authors ' contributions .NT , UT and NZ performed study conception and design .NT , GC , MR and NM performed data collection , analysis and interpretation .", "label": "", "metadata": {}, "score": "83.32173"}
{"text": "The estimated overall survival and metastasis - free survival were respectively 98 % , 98 % and 99 % , 98 % at 36 and 60 months .", "label": "", "metadata": {}, "score": "83.32337"}
{"text": "The significant benefit of Intensity Modulated PROTON Therapy is now beginning to be realized - There is no disputing that IMRT has become a mature technology since its introduction in 1998 .", "label": "", "metadata": {}, "score": "83.36812"}
{"text": "Toxicity analysis for gastrointestinal and genitourinary sites was performed using the National Cancer Institute Common Toxicity Criteria for Adverse Events , version 3 .Follow - up for this analysis was completed during October 2010 .", "label": "", "metadata": {}, "score": "83.496994"}
{"text": "SBRT can be delivered safely using any of several commercially available treatment systems .In some cases the dose delivery involves a combination of multiple non - coplanar beams aimed at the target , and in other systems the delivery is accomplished with static intensity - modulated beams or rotating modulated arcs .", "label": "", "metadata": {}, "score": "83.80578"}
{"text": "The first dose of radiation kills cells that are well oxygenated and in sensitive phases of cell cycle .Palliation and prevention of symptoms of disease .", "label": "", "metadata": {}, "score": "83.9382"}
{"text": "TREATMENT Tropical anesthetics , inflammatory muscle analgesic , relaxants depressants .CONCLUSION Radiation therapy place an integral role in management of most head and neck malignancies .", "label": "", "metadata": {}, "score": "84.045525"}
{"text": "Assuming that the bin size and the density remain the same , EQID is defined by the equation : . where D 1kj and d 1kj represents respectively the total dose and the fraction dose of voxel k in organ j , and \u03b1 / \u03b2 is the specific organ radiation sensitivity .", "label": "", "metadata": {}, "score": "84.14877"}
{"text": "It is generally believed that leakage through the leaves of a conventional collimator might carry a significant contribution to peripheral integral dose ( leakage is about 2.5 % for 6 MV photon beams ) .", "label": "", "metadata": {}, "score": "84.324646"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. J. Hall and D. J. Brenner , \" The radiobiology of radiosurgery : rationale for different treatment regimes for AVMs and malignancies , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "84.37612"}
{"text": "ratio of 1.5 .At the median follow - up of 41 months , there were no instances of grade 3 GI toxicity and only a single episode of acute grade 3 GU toxicity .", "label": "", "metadata": {}, "score": "84.42433"}
{"text": "The Memorial Sloan Kettering group definition was used to classify patients into risk groups [ 18 ] .Eligibility criteria were clinically and radiographically organ - confined disease with freedom from lower urinary tract symptoms requiring treatment .", "label": "", "metadata": {}, "score": "84.45913"}
{"text": "The SBRT technique consisted of intensity - modulated radiotherapy ( IMRT ) with daily image guidance using implanted gold fiducials .All patients had at least 6 months of follow - up .", "label": "", "metadata": {}, "score": "84.808044"}
{"text": "The Provision Center for Proton Therapy physicians and staff believe that physicians , patients , and payers should rely on the facts concerning proton therapy ; and we offer you these facts to help in your decisions concerning proton therapy .", "label": "", "metadata": {}, "score": "85.105255"}
{"text": "Introduction .GBM , a WHO grade IV glioma , is the most common and most malignant primary central nervous system tumour .Currently , the standard of care for these patients is safe , maximal surgical resection , if possible , followed by postoperative RT with concomitant TMZ followed by six cycles of adjuvant TMZ as established by the 22981/26981-EORTC / NCIC phase III trial [ 1 ] .", "label": "", "metadata": {}, "score": "85.11882"}
{"text": "Cells tend to be more radiosensitive in mitosis and late G1 - early S phase than in early G1 and G2 phases .So , radiation perferentially kills cells in the more sensitive phase of cell cycle .", "label": "", "metadata": {}, "score": "85.2171"}
{"text": "The mean dose to the PTV was 60.8 Gy ( SD \u00b1 2.7 ; range 43.6 - 65.6 ) .The maximum dose received by the optic chiasm , optic nerves and brain stem was 40.5 Gy \u00b1 7.6 , 34.6 Gy \u00b1 11.5 , and 50.7 Gy \u00b1 10.3 , respectively .", "label": "", "metadata": {}, "score": "85.267654"}
{"text": "The ID attempts to describe energy deposition within the whole body and it is historically considered as a physical quantity capable of representing the \" physical aggression \" and risk of complications due to radiation therapy .", "label": "", "metadata": {}, "score": "85.58559"}
{"text": "For the differential DVH to be calculated , the volumes of interest ( PTV , body , OARs ) are divided into a volume grid made of equal - sized bins .", "label": "", "metadata": {}, "score": "85.683044"}
{"text": "Although there were initial grade 2 toxicities ( 13 % GU and 7 % GI ) , these scores returned to or improved over baseline at 6 months .", "label": "", "metadata": {}, "score": "85.91768"}
{"text": "The authors indicated no potential conflicts of interest .Authors ' contribution .All authors read and approved the final manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "85.92837"}
{"text": "Review of Hypofractionated Radiotherapy for Prostate Cancer .Department of Radiation Oncology and Stereotactic Radiotherapy , Medical School , University of Patras , 26504 Patras , Greece .", "label": "", "metadata": {}, "score": "86.07441"}
{"text": "In terms of GU toxicity , there was worse grade 2 + toxicity at 5 years with hypofractionation .This toxicity for hypofractionation is similar to other modalities .", "label": "", "metadata": {}, "score": "86.19704"}
{"text": "The dose constraints for the aforementioned organs were a maximum dose of 50 Gy for brainstem , 40 Gy for spinal cord , 45 Gy for the optic chiasm and optic nerves , and 10 Gy for the orbits .", "label": "", "metadata": {}, "score": "86.35301"}
{"text": "Late responding tissue - spinal cord .The early responding tissues limit both the size of dose fraction and the degree to which time course of radiation can be compressed .", "label": "", "metadata": {}, "score": "86.66022"}
{"text": "PubMed View Article .Chen C , Damek D , Gaspar LE , Waziri A , Lillehei K , Kleinschmidt - Demasters BK , et al .", "label": "", "metadata": {}, "score": "86.68435"}
{"text": "The patients ' baseline characteristics are summarized in Table 1 .The median age at diagnosis was 53.1 years ( range , 22.6 - 73.4 years ) .", "label": "", "metadata": {}, "score": "86.758224"}
{"text": "This work has been supported in part by an Investigator - Initiated Research Grant from Nucletron B.V. , Veenendaal , The Netherlands .Competing interests .", "label": "", "metadata": {}, "score": "86.891136"}
{"text": "Res .Cancer Res .[ Google Scholar ] [ CrossRef ] .Khan , F.M. The Physics of Radiation Therapy ; Lippincott Williams & Wilkins : Philadelphia , PA , USA , 2003 ; pp .", "label": "", "metadata": {}, "score": "87.02147"}
{"text": "Presenter : V.V. Thakkar Presenter 's Affiliation : Department of Radiation Oncology , The Cleveland Clinic Foundation , Cleveland , OH Type of Session : Scientific .", "label": "", "metadata": {}, "score": "87.31384"}
{"text": "Parameters used for EAR calculation according to Equations ( 4)-(7 ) .For each organ , the parameters \u03b2 ( expressed as excess case per 10,000 PY / Gy ) , \u03b3 e , \u03b3 a and R were taken from [ 30 ] .", "label": "", "metadata": {}, "score": "87.40587"}
{"text": "Parameters used for EAR calculation according to Equations ( 4)-(7 ) .For each organ , the parameters \u03b2 ( expressed as excess case per 10,000 PY / Gy ) , \u03b3 e , \u03b3 a and R were taken from [ 30 ] .", "label": "", "metadata": {}, "score": "87.40587"}
{"text": "303 of 307 ( goal 300 ) evaluable patients were enrolled on the prospective randomized trial between 2002 and 2006 .Of these , 152 were assigned to receive CIMRT and 151 to receive HIMRT .", "label": "", "metadata": {}, "score": "87.64554"}
{"text": "[ Google Scholar ] .Clarke , M. ; Collins , R. ; Darby , S. ; Davies , C. ; Elphinstone , P. ; Evans , E. ; Godwin , J. ; Gray , R. ; Hicks , C. ; James , S. ; et al .", "label": "", "metadata": {}, "score": "88.29196"}
{"text": "[ 22 ] reported on the National Institute of Radiological Sciences experience on 201 patients using carbon ion therapy in the hypofractionated treatment of prostate cancer during three clinical trials in Japan from June 1995 to February 2004 .", "label": "", "metadata": {}, "score": "88.85564"}
{"text": "All 351 patients had histologically proven disease and were staged according to the American Joint Committee on Cancer , 6 th edition , staging guidelines .", "label": "", "metadata": {}, "score": "88.999214"}
{"text": "Toxicity .Table 3 shows the distribution of acute toxicity for the total group of 351 patients .Part of the data was presented at the 2007 German Society of Radiation Oncology meeting [ 21 ] .", "label": "", "metadata": {}, "score": "89.52923"}
{"text": "In Basics Clinical Radiobiology ; van der Kogel , A. , Joiner , M. , Eds . ; Hodder Arnold Publication : London , UK , 2008 .", "label": "", "metadata": {}, "score": "89.90251"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Radiation Oncology , Klinikum Offenbach .Department of Urology , Klinikum Offenbach .", "label": "", "metadata": {}, "score": "90.05897"}
{"text": "Early reacting tissues such as the skin , the intestinal epithelium , and tumours have a large \u03b1 / \u03b2 value of about 10 Gy , whereas late reacting tissues such as the brain and bone have a smaller \u03b1 / \u03b2 value of 2 - 3 Gy .", "label": "", "metadata": {}, "score": "90.1982"}
{"text": "The main payer for cancer treatment in the United States is Medicare whose coverage policy includes payment for prostate cancer treatment .In addition , there are many commercial payers who have favorable coverage policies for proton therapy prostate cancer treatment including the nation 's second largest payer , Wellpoint .", "label": "", "metadata": {}, "score": "90.645004"}
{"text": "The CyberKnife is a frameless miniature robotic linear accelerator that uses image - guided radiotherapy ( IGRT ) in order to treat tumors in different parts of the body , including the prostate .", "label": "", "metadata": {}, "score": "90.87303"}
{"text": "Radiotherapy has been often described as a \" two edged sword \" because , if on one hand it is a major modality of cancer treatment , but on the other it can be a cause of cancer .", "label": "", "metadata": {}, "score": "93.10107"}
{"text": "PubMed .Copyright .\u00a9 Jastaniyah et al ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.Radiotherapy /certified fixed orthodontic courses by Indian dental academy .", "label": "", "metadata": {}, "score": "93.38947"}
{"text": "The trial was performed over a period of 7 years from 1996 to 2003 at a single centre .Patients were required to have TI or T2 disease , but there were no PSA or Gleason score requirements .", "label": "", "metadata": {}, "score": "93.39116"}
{"text": "Integral Dose and Radiation - Induced Secondary Malignancies : Comparison between Stereotactic Body Radiation Therapy and Three - Dimensional Conformal Radiotherapy .National Institute of Ionizing Radiation Metrology , ENEA Casaccia Research Center , Rome , Italy / Via Anguillarese 201 , Rome 00123 , Italy .", "label": "", "metadata": {}, "score": "93.772705"}
{"text": "Conclusions .Our results confirm high dose rate brachytherapy as safe and effective monotherapy for clinically organ - confined prostate cancer .Keywords .Prostate cancer Brachytherapy High dose rate Iridium Monotherapy .", "label": "", "metadata": {}, "score": "93.94719"}
{"text": "What is Cyberknife ?Despite the name , Cyberknife is not a surgical instrument and there is no cutting involved in the treatment .Cyberknife is a treatment using external beam radiation and was FDA approved in 2001 .", "label": "", "metadata": {}, "score": "94.92714"}
{"text": "Med .Biol .2008 , 53 , R193 .[ Google Scholar ] [ CrossRef ] .The 2007 recommendations of the International Commission on Radiological Protection .", "label": "", "metadata": {}, "score": "95.14691"}
{"text": "The rates of grade 1 , 2 , and 3 acute GU toxicities were 29 % , 31 % , and 5 % , respectively .", "label": "", "metadata": {}, "score": "95.38867"}
{"text": "The Provision Center for Proton Therapy Response to the L.A. Times Article Dated August 28 , 2013 and the Wall Street Journal Article of August 29 , 2013 on Health Insurer Payment Policies for Proton Therapy - August 30 , 2013 .", "label": "", "metadata": {}, "score": "98.31163"}
{"text": "According to this approach , for any three - dimensional inhomogeneous dose distribution , the excess absolute risk ( EAR ) can be calculated using the formalism described in [ 30 ] and based on the concept of organ equivalent dose , OED [ 28 ] .", "label": "", "metadata": {}, "score": "98.47812"}
{"text": "Organs at risk ( OAR ) including the optic nerves , optic chiasm , optic apparatus ( right and left optic nerves and optic chiasm ) , brainstem , spinal cord and right and left eyes were contoured in each slice .", "label": "", "metadata": {}, "score": "99.4075"}
{"text": "10 , pp .2832 - 2848 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .57 , no . 2 , pp .", "label": "", "metadata": {}, "score": "101.05905"}
{"text": "Materials and Methods .Integral Dose Evaluation .The integral dose ID to an organ j divided into m voxels is given by the following equation : . where v kj , D kj and \u03c1 kj are respectively the volume , dose and density of voxel k in organ j .", "label": "", "metadata": {}, "score": "101.243164"}
{"text": "EXTERNAL THERAPY ( Teletherapy ) X - rays Source / Point of Origin is at a distance away from patients body .In external therapy two principal field arrangements are parallel opposed fields and wedged pair fields .", "label": "", "metadata": {}, "score": "101.88258"}
{"text": "988 - 993 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .68 , no .5 , pp .", "label": "", "metadata": {}, "score": "102.94275"}
{"text": "According to the model proposed by Schneider et al .[ 27 , 28 , 29 , 30 ] , if the dose - volume histogram V ( d ) of an organ or region of interest is known , the excess absolute risk in that organ , EAR org , can be calculated as follows : . where V T is the total organ volume and \u03b2 is the slope of the dose - response curve at low dose .", "label": "", "metadata": {}, "score": "103.606735"}
{"text": "All SBRT plans were generated with BrainSCAN TPS ( BrainSCAN TM v.5.2.1 , BrainLAB AG .Heimstetten , Germany ) implemented with pencil beam algorithm and heterogeneity corrections as well .", "label": "", "metadata": {}, "score": "103.764145"}
{"text": "5 , pp .1035 - 1041 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .51 , no .", "label": "", "metadata": {}, "score": "103.848564"}
{"text": "4 , pp .234 - 239 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .52 , no . 1 , pp .", "label": "", "metadata": {}, "score": "104.69162"}
{"text": "5 , pp .1035 - 1041 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .65 , no .", "label": "", "metadata": {}, "score": "104.845314"}
{"text": "36 , no . 2 , pp .107 - 111 , 1990 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "105.37312"}
{"text": "10 , pp .729 - 737 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .73 , no .", "label": "", "metadata": {}, "score": "105.59107"}
{"text": "74 , no .4 , pp .1121 - 1127 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "105.70121"}
{"text": "44 , no .4 , pp .747 - 748 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "105.98093"}
{"text": "228 - 234 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .63 , no .5 , pp .", "label": "", "metadata": {}, "score": "107.48503"}
{"text": "965 - 974 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .67 , no .4 , pp .", "label": "", "metadata": {}, "score": "107.825485"}
{"text": "24 - 33 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .82 , no . 1 , pp .", "label": "", "metadata": {}, "score": "110.77983"}
{"text": "Radiat .Oncol .[ Google Scholar ] [ CrossRef ] .\u00a9 2012 by the authors ; licensee MDPI , Basel , Switzerland .Abstract .", "label": "", "metadata": {}, "score": "110.98755"}
{"text": "4 , pp .1072 - 1083 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .View at Google Scholar .", "label": "", "metadata": {}, "score": "115.83623"}
{"text": "Academic Editor : Rami Ben - Yosef .Copyright \u00a9 2013 L. Chinsoo Cho et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "118.409"}
{"text": "Medical Physics Department , Sant'Andrea Hospital , University of Rome La Sapienza / Via di Grottarossa , 1035 - 1039 , Rome 00189 , Italy ; Email : .", "label": "", "metadata": {}, "score": "119.59961"}
{"text": "Received : 28 August 2012 ; in revised form : 15 October 2012 / Accepted : 19 October 2012 / Published : 19 November 2012 .", "label": "", "metadata": {}, "score": "120.21492"}
{"text": "Medical Physics , Cross Cancer Institute and University of Alberta .Division of Statistics and Epidemiology , Cross Cancer Institute and University of Alberta .Department of Oncology , Division of Radiation Oncology , Montreal General Hospital , McGill University .", "label": "", "metadata": {}, "score": "122.713974"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .68 , no .5 , pp .1424 - 1430 , 2007 .", "label": "", "metadata": {}, "score": "125.08235"}
{"text": "View at Google Scholar .81 , pp .1271 - 1278 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "128.80069"}
{"text": "View at Google Scholar \u00b7 View at Scopus .52 , no . 1 , pp .6 - 13 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "135.82288"}
{"text": "Copyright \u00a9 2012 Despina Spyropoulou and Dimitrios Kardamakis .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "141.13354"}
